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ABSTRACT

MOLECULAR CHARACTERIZATION OF A CYTOTOXIC-PORIN
PROTEIN FROM CAMPYLOBACTER JEJUNI AND ITS
ROLE IN CAMPYLOBACTERIOSIS
by
David J. Bacon
University o f New Hampshire, May, 1997.

Campylobacterjejuni is a major cause o f enteritis in developed and developing
countries. A cytotoxic complex was isolated from organism-free filtrates o f broth grown
organisms by screening for activity in HEp-2 cells following high performance liquid
chromatography using a combination of size exclusion and DEAE column
chromatography. The toxin was found to coincide with a 45 kDa protein possessing an
N-terminus sequence indicative o f a bacterial outer membrane porin protein together with
a high molecular weight carbohydrate which was determined to be lipopolysaccharide
(LPS).
The carbohydrate portion o f the LPS had reactivity for the lectins Galanthus

nivalis agglutinin, MaaJda amurensis agglutinin and Datura stromonium agglutinin The
cytotoxicity o f the porin-LPS complex was heat-labile at 70 ° C within 30 min. It was also
found to be resistant to trypsin and to degradation by the enzymes neuriminidase and
glycosidase F as well as to oxidation with sodium meta-periodate. The complex induced
DNA fragmentation, cytoplasmic blebbing and nuclear condensation in HEp-2 cells alter
24 h o f intoxication possibly indicating that the cells were becoming apoptotic.

x
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Oligonucleotides were generated from the N-terminus o f the porin protein. Using
a combination o f vectorette and inverse polymerase chain reaction (PCR) and cloning, a
1.45 kb fragment was sequenced and found to contain a 1275 base pair (bp) open reading
frame (ORF). The ORF, designated porA encoded a 424 amino acid protein with a 22
residue leader sequence and had a calculated molecular weight o f 45.6 kDa and pi o f 4.44.
The mature protein was 402 amino acids in length and had a molecular weight o f 43.5 kDa
and a p i o f 4.35. The translated PorA protein had a 50% sequence homology with

Haemophilis influenzae major outer membrane protein P2. Thirty-two strains of
Campylobacter sp. and closely related organisms were screened for the porA gene and
expression o f cytotoxin in cell culture. Although all strains examined produced a
cytotoxin, 21 o f the 32 strains (66%) were genotypically positive for porA and o f these 21
o f 23 (91%) were C. jejuni strains. It is postulated that this cytotoxic protein is a major
virulence factor for C. jejuni and may be responsible for the clinical symptoms usually
associated with campylobacteriosis.

xi

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

SECTION I
A Historical Perspective of the Genus Campylobacter and
Campylobacteriosis.

1.1 History of campylobacteriaceae.
la 1913 when bacterial taxonomy was primarily based on phenotypic
characterization, Mcfadyean and Stockman classified a previously unknown organism
isolated from an aborted ovine fetus as a " F/'Z»r/o"-like bacterium (228.254). The
designation was based on the morphology o f the organism at the time it was first isolated.
Later that same decade, spiral bacteria were again identified in an aborted bovine fetus by
Smith (233) who named the organism Vibrio fetus. It was his belief that the organism he
found was the same as the one previously described in 1913. Two more vibrio-like
organisms, V fetus subsp. venerealis and V. fetus subsp. intestinalis were discovered
subsequently and linked to fertility problems in cows and ewes respectively (70). These
microorganisms have since been reclassified and are now formally recognized as

Campylobacterfetus subsp. venerealis and C. fetus subsp. fetus.
In 1927, the microbiologists Smith and Orcutt (234) were the first to document
the presence o f vibrio-like organisms in the feces of cattle with diarrhea. Further
investigations in 1931 by Jones (111) showed that there was a significant correlation
between bovine dysentery and the presence o f these microaerophilic vibrios. These
organisms were to become known as Vibrio jejuni (112) and similar bacteria were also
found in the blood o f patients with diarrhea (125) and aborted sheep fetuses (28). In
1943, another vibrio was isolated from pigs with diarrhea by Doyle and the organism was

l
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categorized as Vibrio coli (58). Several additional Vibrio species including V. sputorum,

V. bubulus and V faecalis, were isolated and classified according to morphological
characteristics and a name assigned representative o f the site at which they were first
isolated. Specifically, V sputorum was isolated from a patient with bronchitis (251), V.

bubulus from the preputial cavities o f cattle (195) and V. faecalis from sheep feces (195).
It was not until 1963 that researchers took a less descriptive approach to
classifying the vibrios which had been isolated from symptomatic humans and animals. It
was already known that the new vibrio-like organisms were microaerophilic, a feature not
common to other Vibrio sp. In addition, the % Guanidine/Cytosine (%GC) content in the
deoxyribonucleic acid (DNA) o f the new strains was found to be between 29-36 mol %
while classic Vibrio sp. have a much higher %GC in the range of 40 to 53 mol % (253).
Furthermore, the newly discovered “vibrio-like” organisms were unable to ferment
carbohydrates present in bacteriological media, a characteristic which is not common with
other o f Vibrio sp. (254). In view o f these traits, Sebald and Veron reclassified V. fetus
and V bubulus into a newly defined genus referred to as Campylobacter, the Greek word
for curved rod (228). Veron and Chatelain (254) undertook a more comprehensive study
in which they reclassified Vibriojejuni, V sputorum, V coli, and V fetus as

Campylobacterjejuni, C. sputorum, C. coli, and C. fetus respectively. The isolate o f C.
fetus they identified and characterized was a neotype strain distinct from the isolate
reclassified in the 1963 study (254). Several new strains o f Campylobacter have since
been discovered and currently there are a total o f 18 species and subspecies within the
genus (40) (Table 1.1). Most, but not all o f the currently known species are capable of

2

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

causing disease in humans or animals, dispite this, most o f the pathogenic mechanisms
associated with the different species remain to be elucidated. The role o f cytotoxins
and/or enterotoxins in the dianheal response has been the subject o f many intensive
investigations (257,259). Although there remains much controversy over the role toxins
play in the infectious process, several cytotoxins (86.150) and at least one enterotoxin (14)
have been implicated in the pathogenesis o f disease.

1.2 Taxonomy of Campylobacteriaceae.
The first taxonomic studies conducted on the genus Campylobacter primarily
addressed the physical characteristics o f the bacteria (254). The early studies compared
growth rates on different media and at different temperatures monitored by microscopic
examination o f motility and flagellar staining. Biochemical tests included oxidase, indole,
catalase, nitrate reductase, H 2 S production, glucose metabolism, and gelatin hydrolysis
(254). To further classify the genus, tolerance tests were conducted using various
concentrations o f compounds such as glycine and bile along with antibiotic sensitivity
testing (254). The % GC was determined and the identified strains were typed
serologically using two antisera specific for the heat stable antigens (254). This study
provided valuable information regarding the identified strains o f Campylobacter and
provided criteria for future identification and classification o f the organisms within the
genus (Table 1.1).
hr 1974 the genus Campylobacter was grouped with Spirillum in the family of

Spirillaceae in Bergey*s Manual o f Determinative Bacteriology (231). This type of
classification, based on common morphological and physiological characteristics, remained
intact until 1984, at which time Sergey's Manual discontinued the family name

Spirillaceae and grouped Campylobacter, Spirillum and Aquaspirillum together in one
group. This classification prevailed until 1987 when a more in-depth approach led to the

3
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reclassification

o f Campylobacters in the same group as the other Gram-negative bacteria

(191). A t this time, a study was conducted comparing partial 16S rRNA sequence data
from 6 different Campylobacter species, including a strain o f C. pylori (191). This genetic
analysis showed that Campylobacters belonged to a previously undescribed eubacterial
group closely related to Thiovulum, a microaerophilic sulphur-accumulating aquatic
bacterium (191). Further analysis showed Campylobacter w as related to the phylum o f
purple photosynthetic bacteria commonly known as Proteobacteria (170). Additionally, it
was found that C. pylori was more closely related to the genus Wolinella than the other

Campylobacter species investigated (216). Upon closer examination of known
Campylobacter species, three distinct rRNA groups were found. Current nomenclature
places the true Campylobacters such as C. fetus and C. jejuni in group I while groups II
and HI have been reclassified as Helicobacter sp. and Arcobacter sp. respectively (Fig 1.1)
(253).

1.3. Identification and characterization of C. jeju n i
Campylobacter sp. are microaerophilic, curved or S-shaped rods approximately
0.2 to 0.9 pm wide and 0.5 to 5 pm long. They are non spore-forming, gram negative
rods which may form coccoids following prolonged exposure to air and are motile by
unsheathed polar or bipolar flagella (172). C. jejuni are catalase positive, urease negative,
hydrolyze hippurate, nalidixic ad d sensitive and resistant to cephalothin (172) (Table 1.1).
In a clinical setting C. jejuni are readily distinguished from the closely related species, C.

coli, by determination of hippurate hydrolysis activity. Originally, Campylobacter were
differentiated solely on the basis o f bacteriophage type but later this approach was
expanded to include biotype (147). Today there are 10 methods which are routinely used
for differentiating Campylobacter, (i) serotype (147, 160); (ii) biotype (227); (ii)
phagetype (120); (iv) pulsed-field gel electrophoresis (PFGE) (227); (v) ribotype (227);

5

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

fe tu s

E

hyointestinalis

•C am pylobacter

4L,-C am pylobacter

,

concisus
m ucosalis

* - - - CLO strain CCUG 20705

rRNA cluster I

----------C ampylobacter sputorum
•Campylobacter curvus
[Campylobacter rectus
'W olinella sp CCUG 11641
i
C am pylobacter upsaliensis
-C a m p y lo b a c te r
C am pylobacter
B acteroides
Bacteroides

I— j e j u n i

ureolyticus
gracilis
-A rcobacter nitrofigilis
-C L O strain CCUG 10373
- - - Arcobacter cryaerophilus

l
l

lari

con

------------- CLO strain s

- CLO-3
F lexis pira
Helicobacter
Helicobacter
Helicobacter
H elicobacter

CCUG

10374

CCUG

10375

E

rappini
W olinella

succinogenes

rRNA cluster II

rRNA cluster III

cinaedi
m ustelae
fe n n e llia e
p ylo ri

Spirillum 5 1 7 5
CLO strain CCUG 13942

rRNA superfam ily I to V
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(vi) restriction endonuclease patterns (69, 173.184); (vii) random amplified polymorphic
genomic D NA (RAPD) (67); (iix) plasmid profile (33); (ix) whole cell protein
profile(227); and (x) polymerase chain reaction (PCR) specific for C. jejuni DNA (55).
With these typing methods firmly established, it is possible to obtain valuable
epidemiological information regarding probable sources o f C. jejuni infections and cross
contamination. Currently there are two well defined serotyping methods for

Campylobacter sp. One o f the serotyping schemes currently used for Campylobacter sp.
is a passive hemagglutination assay based on heat-stable antigens which is commonly
referred to as the Penner serotyping scheme (160). This method involves typing of the O
antigen by allowing it to first sensitize erythrocytes followed by a slide agglutination assay
with strain-specific antisera (160). Another serotyping scheme is based on the heat-labile
factors and commonly referred to as the Lior serotype (147). It also utilizes slide
agglutination assay technique using live bacteria and whole cell antisera absorbed with
homologous heated and heterologous unheated cross-reactive antigens (147). Of the C.

jejuni strains examined, there are 47 Penner serotypes and 55 Lior serotypes of human
origin, 11 from non-human sources and 8 that are unknown (147).
Since a large number o f strains belong to common serotypes, it is often necessary
to further differentiate each serotype and a biotyping scheme was proposed in 1980 by
Skirrow and Benjamin to further sub-divide the more common serotypes (227). The
investigators evaluated hippurate hydrolysis, production o f HfeS on media containing
ferrous, bisulfite and pyruvate (FBP) components and resistance to naladixic acid in order
to subdivide C. jejuni into two biotypes (227). In 1984, Lior proposed a new biotyping

7
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scheme using hippurate hydrolysis, production o f H 2 S on FBP medium and DNA
hydrolysis which further divided C. jejuni into four biotypes, providing further information
for epidemiologic purposes (227). C. jejuni can also be further sub-classified based on
phage type (120). By using 22 different typing phages, 52 different phage types have been
identified for C. jejuni (120).
Pulsed-field gel electrophoresis (PFGE) has been used to distinguish very closely
related strains o f C. jejuni. The information collected from PFGE can be used to
determine if one or more strains o f C. jejuni is responsible for an outbreak of
campylobacteriosis. This molecular technique is accomplished by comparing the
chromosomal DNA banding patterns following digestion with specific restriction
endonucleases which have a low frequency o f cleavage sites. Different strains produce
unique banding patterns due to variation in the sizes of fragments resulting from the loss
or gain of restriction sites. PFGE can also be used to determine the average genomic size
o f C. jejuni and C. coli chromosomal DNA when fragments are compared to known
molecular weight standards.
Recently, two molecular typing schemes have been developed for C. jejuni (69,
173). The first is a comprehensive ribotyping typing scheme based on the heat-stable
serotypes. This method uses a 16S rRNA polymerase chain reaction (PCR) generated
amplicon in Southern blot analysis with genomic DNA previously digested with either Pstl
or HaeTR (69, 185). This particular technique has identified 77 unique types o f C. jejuni
based on banding patterns and shows there are three copies of the 16S rRNA gene (69).
A second method uses restriction fragment length polymorphism (RFLP) analysis of a 1.7-
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kb amplicon generated from the flaA gene o f C. jejuni following digestion with Dde I
(173). Although only a limited number o f strain s were used, the results showed that this
method can discriminate between strains and determine copy numbers o f the flaA genes
(69, 173). RAPD has also been used for molecular typing (67). This typing method
utilizes random, single 10-mer primers in the PCR reaction followed by separation of
amplicons using agarose gel electrophoresis. Groupings o f strains based on the flaA
amplicons were found to be similar to the groups obtained using the ribotyping scheme
(67).
Plasmid profiles o f various strains o f C. jejuni from human and non-human sources
have been analyzed with respect to size, number and frequency o f extrachromosomal
DNA (33). Plasmids were found in 22% o f hum an isolates and ranged in size from 3 .2 - to
60-Mda (33) while 12.7% o f non-human isolates contained plasmids ranging from 1.3- to
82-Mda (33). Plasmid profiles could be used for epidemiological purposes along with
antibiotic resistance since tetracycline resistance is commonly carried on a 3 3 - to 41-Mda
plasmid (33, 249).
Protein banding patterns observed following non-denaturing polyacrylamide gel
electrophoresis (PAGE) have also been found useful in distinguishing species o f
Campylobacters (114, 227). By analyzing the soluble proteins o f atypical strains following
PAGE and Coomassie blue staining, it was possible to correctly identify these strains to
the species and subspecies levels (227).
Several techniques have been developed to isolate C. jejuni directly from the
environment and patient specimens. It was shown that a combination o f a blood-free
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medium supplemented with cefoperozone and blood agar overlaid with a 0.65 pm filter

was useful for isolation o f C. jejuni from clinical specimens (5). Filtering techniques in
conjunction with PCR have also proved suitable for detection of C. jejuni from water
supplies used on broiler farms (186) and from estuarine surface waters (96). Both
methods use PCR to target a conserved region o f the flaA gene followed by hybridization
with a non-radioactive probe specific for the amplified region. C. jejuni has also been
identified directly in stool by using PCR specific for the flaA gene. By performing DNA
purification using an extractor column directly on stool specimens, it was possible to
identify and type C. jejuni in one step without needing to first culture the organism (255).
Several additional techniques based on hybridization with a species-specific DNA
probe have been developed and these allow for identification o f C. jejuni in as little as 48 h
(32,137,237). However, DNA probes are not the only means o f identifying the organism
using molecular techniques. The use o f monoclonal antibodies attached to magnetic
beads, followed by PCR specific for the 16S rRNA of C. jejuni, has been shown to be
effective in detecting the organism in milk and poultry samples (55). The use of
monoclonal antibodies specific for membrane proteins was also able to identify C. jejuni in
stools (38). While species-specific antibodies can be used to differentiate between
thermophilic Campylobacters as well (84), targeting the gene for specific membraneassociated proteins such as mapA has proven an effective method to speciate C. jejuni
(237).

10
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1.4 Epidemiology an d Disease.

1.4.1. Incidence o f Disease.
Campylobacter enteritis is mainly associated with two closely related species in
rRNA group I: C. jejuni and C. coli (171, 172,230). Although most laboratories do not
distinguish between the two, an estimated 90% o f Campylobacters isolated are C. jejuni
(242). The exact number o f Campylobacter cases each year is difficult to determine since
most go undiagnosed and many are not reported accurately. Voluntary laboratory
reporting o f Campylobacter cases in the United States has shown an incidence o f infection
of 6 to 7/100,000, while active surveillance reveals an incidence o f infection to be 3060/100,000 (230, 242, 243). When surveys were conducted in a general practice in
England, an incidence o f infection o f 1/100 was found (230) and similar studies conducted
in the U.S. following a waterborne outbreak revealed a similar incidence o f infection
(10/1000) (172, 230). Extrapolating these incidence rates o f Campylobacter infections to
the total population o f the United States, an estimate o f 2.5 million cases o f
campylobacteriosis must occur annually (172,230) although most are not reported.
When compared to the incidence o f other enteric pathogens such as salmonellae
and shigellae, Campylobacter sp. are isolated twice as often as Salmonella sp. and four
times as frequently as Shigella sp. (242). hi New Hampshire, campylobacteriosis has
consistently been the fourth most common notifiable disease ahead o f salmonellosis and
behind giardiasis (242). Although not usually life threatening, each case o f

Campylobacter has been estimated to cost approximately 500 dollars (US) in health care
and lost productivity, making Campylobacter enteritis a multi-million dollar disease (230).
The incidence o f campylobacteriosis in developing countries has been estimated to
be several orders o f magnitude higher than that in developed countries (243). For
example, in the region previously known as Yugoslavia, the incidence o f infection in adults
is equivalent to that in the United States, but in children 1-4 years o f age there are an
estimated 2500 cases for every 100,000 children (243). The incidence is even higher in
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Mexico and Thailand where there are approximately 0.4 episodes per child per year with
an annual rate o f 40,000 cases/100,000 population (193,243). Recurrent infections are
also much more frequent in developing countries, hi Thailand for example, a twelve-week
study showed that 10% o f children tested under 5 years o f age had weekly Campylobacter
infections caused by different serotypes (243) and in Mexico, multiple serotypes of

Campylobacter could be isolated from children during any given infection (243).
When excretion rates were examined in the Mexican and Thailand studies, it was
found that isolation from healthy individuals was not due to carriage but was attributed to
reinfection (243). Campylobacter sp. have been clearly linked to travelers' diarrhea when
travel has included developing countries and in these cases the severity o f disease was
found to be greater than that typically seen in the country o f travel (243). In industrialized
countries the average duration o f symptoms is between 1-7 days but an infected individual
can shed the organism for up to 3 weeks following ingestion. The duration o f shedding of
organisms is much lower in developing countries with an average length o f time o f 14 days
for adults and only 8 days for children aged 1 to 5 years. Shorter durations o f shedding
could be attributed to actively acquired natural immunity rendering the children partially
resistant (243).
Symptoms associated with campylobacteriosis include abdominal pain, fever,
cramping, vomiting and diarrhea with or without blood and fecal leukocytes (172, 230,
243). The symptoms tend to be less severe in developing than in developed countries
while the frequency o f mixed bacterial infection is much lower in developed than
developing countries. Whereas most cases of campylobacteriosis are self-limiting, some
instances require treatment with macrolids or fluoroquinolones to resolve the infection and
eliminate

symptoms (172). Antibiotic resistance to erythromycin (245), fluoroquinolones

(227,260), kanamycin (248) and tetracycline (249) are being seen more frequently and
these emerging pathogens may pose a serious problem in the future with respect to
effective treatment and prevention o f Campylobacter infections.
12
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1.4.2. Distribution o f Campylobacter.
Seasonal distribution o f campylobacteriosis is much different in developed than in
developing countries. In developed northern countries, C. jejuni infections are lowest
during the first and last four months o f the year with a surge in the summer months
beginning in May (229, 230, 242, 243). The highest number o f cases are observed in July
and August, possibly due to poor handling techniques o f infected food products (229,
242). There is also an increase during the Thanksgiving and the Christmas holiday seasons
due to increased consumption o f turkey and poultry as traditional foods (Fig 1.2). In
developing countries, seasonal and holiday variation is much less o f an issue (243).
There is a bimodal distribution o f disease among age groups in developed
countries with the highest incidences occurring in children less than five years o f age and
in young adults between 20 and 40 years of age (172, 242) (Fig 1.3). Additionally, men
have a higher infection rate than women in all age ranges, but the bimodal distribution is
maintained (242).
C. jejuni survive as commensals in the gastrointestinal tract o f a wide range of
animals which can then serve as reservoirs for human infection (177, 229, 230, 236, 242,
243,). The most common cause o f outbreaks o f C. jejuni is from consumption of
contaminated water or milk The major waterborne outbreaks that have occurred have
usually infected large numbers o f individuals and were readily traced back to the source of
contamination during investigation. This type o f infection usually occurs in areas where
water chlorination is inadequate or where runoff from farms occurs following periods of
heavy rain. Wild birds such as crows, gulls and pigeons frequently harbor C. jejuni and can
therefore readily contribute to the contamination o f untreated drinking
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Figure 1.2. Reported cases of Campylobacter isolates by month in the United
States from 1982 to 1989 (243).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

M ales
— F em o les

p o p u la tio n

16 -

14

-

12-

I s o l a t e s / 100,000

10-

8

-

6

-

2-

1^1—4 1 5 - 9

65-tA ge in y e a r s

Figure 1.3. Distribution of Campylobacter isolates in the United States by age and
sex (243).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

water. Unpasteurized milk has also been linked to large outbreaks o f campylobacteriosis.
In three documented cases attributed to contaminated milk, 148, 200 and 2500 individuals
respectively, were infected with C. jejuni (63). A study was conducted to investigate the
incidence o f C. jejuni carriage in diary herds and the results showed that 10 o f the 12
herds tested were positive for the organism and 10-72% o f the cows tested were culture
positive (102).
The most common source o f sporadic infection in developed countries is through
the consumption o f undercooked chicken (236, 242,243). The infective dose o f C. jejuni
needed to cause disease has been disputed, but may be as low as Kp organisms and
detailed surveys have shown that 60-80% o f commercially available chickens harbor up to
10^ Campylobacter per carcass (172, 236). Measures to remove Campylobacters from

chickens include vaccination o f the flocks, selection of chickens based on their resistance
to colonization with the organism and irradiation of raw meat products. The common
house fly has also been shown to carry C. jejuni and is suspected o f transmitting the
organism to previously uncolonized chickens (229, 236).
Colonization studies using mice show they can excrete viable organisms for
months following exposure making them a potential reservoir for disease, especially on
broiler farms (20). B eef and pork products may also serve as reservoir for disease, most
likely becoming contaminated during processing. Campylobacter have also occasionally
been isolated from fresh vegetables at farmers markets with greater than 80% o f the
isolates being C. jejuni (190).
1.5 Models of Campylobacter disease.
Many animal species have been examined in search o f symptoms typical o f those
observed in human campylobacteriosis and to serve as models for disease. It is not
uncommon for a particular animal to become colonized with the organism without
developing symptoms as evidenced by the large number o f domestic and wild animals that
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are naturally colonized with these organisms This is an important observation since
domestic cats and dogs can be chronic Campylobacter carriers and serve as potential
reservoirs o f infection and disease since they are known to be asymptomatic carriers of the
organism (236). However, in dogs less than 6 months o f age, symptoms such as watery
and bloody mucoid diarrhea can occur (72). Colonization has also been documented in
hamsters and non-human primates living in captivity (72). This type of cross

contamination is especially common in group environments and can lead to colonization
with multiple serotypes o f C. jejuni (72) in animal colonies. Experiments using
gnotobiotic and germ free puppies have been successful in establishing symptoms, but the
high cost needed to maintain adequate facilities have made experimentation with these two
models impractical.
In order to effectively study C. jejuni infections, it is desirable to have a model
which produces those symptoms commonly seen in humans The criteria which must be
met for selection o f a suitable model include: (i) it reproduces the pathology o f the
disease being studied; (ii) the animals are readily available commercially in sufficient
numbers; (iii) it can be easily transported and exported; (iv) it is easy to maintain and
handle in laboratories; (v) it is well characterized biologically; (vi) its disease status is
established; and (vii) it is has a sufficient life span for the study in question (72).
Rabbits serve as suitable models for enteric pathogens such as Vibrio cholerae and
enterotoxigenic Escherichia coli. Researchers have adopted the removable intestinal tie
adult rabbit diarrhea (RTTARD) model to study C. jejuni infection but have had only
limited success (34, 35, 63, 258). The RTTARD model permits enhanced colonization of
the mucosa by inhibition o f normal peristaltic clearance (13, 258). Colonization by C.

jejuni was thought to be facilitated by motility and the RITARD model has allowed for the
in vivo comparison o f disease potential o f motile and nonmotile strains of C. jejuni.
Results indicated that when both flagellate and non flagellate strains were inoculated in the
RTTARD model, only flagellated Campylobacters were isolated from fecal samples
17
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signifying that any colonization 'with nonflagellated organisms which occurred was cleared

more readily (258). The RITARD model has also provided information regarding the
interaction o f the organism with the intestinal epithelial cells and has enabled evaluation of
the organism for exotoxin production.
Mice have been used extensively as an infection model since they typically do not
contain Campylobacter sp. as part o f their normal flora and because o f the ease and the
low cost associated with their use and maintenance (72). They have been used primarily
for colonization studies because they do not generally exhibit the clinical symptoms
associated with C. jejuni enteritis. Experiments have been performed to enhance the
virulence o f C. jejuni by intraperitoneal passage in weanling pups using mucin or iron
dextran. Following intragastric intubation o f passaged organisms into neonatal mice, the
mice developed self-limiting campylobacteriosis. The LD 5 0 o f the virulence-enhanced
strain was found to be 6-fold lower than before passage, thereby showing it to be an
effective method for this purpose (116).
A mouse model was developed to evaluate colonization o f mucus as a pathogenic
mechanism for C. jejuni (144). The organism was able to colonize the outer surfaces of
the mucus as well as deep within the intestinal crypts in gnotobiotic and germ free mice
without evidence o f adherence to epithelial cells (144). The organism is highly motile in
the mucus, and this is facilitated by its spiral shape which may help it colonize deep within
the crypts thus protecting it from the peristaltic clearance action o f the intestine. Rat ileal
loops have also been evaluated, and by this method the production o f a cholera-like
enterotoxin by C. jejuni was documented (220).
A chick embryo model has been used to assess virulence and invasiveness o f C.

jejuni (67, 68, 126, 150). Results show that the strain o f C. jejuni and the host lineage of
the chickens used can dramatically alter the outcome o f the experiment, providing insight
that virulence may be very strain-specific (126). Infant chicks, between 3 6 - to 7 2 h old,
have also been shown to exhibit campylobacteriosis similar to that in humans following
IS
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ingestion o f the organism (223). Invasiveness has also been studied using primary swine
intestinal cells and results suggest invasion is an in vivo virulence characteristic o f the
organism (13).
The use o f the Macaca nemestrina monkey as a model for disease has been
reported (217.219) but due to the high cost associated with such a model, it has proved
difficult to evaluate. Campylobacter sp. are commonly isolated from symptomatic
monkeys in captivity showing that they can be colonized and infected in a fashion similar
to humans. These animals^ like human

also acquire protective immunity following

subsequent exposure to the organism (217, 218, 258).
The most widely accepted model for campylobacteriosis is the domestic ferret
model (17, 18, 19, 73, 74). Ferrets are readily available and relatively easy to maintain,
but more importantly, they have a gastrointestinal tract anatomically similar to humans
(74). Ferrets have provided a model in which the immun e response to C. jejuni can also
be evaluated (17). Results show that passively acquired maternal antibodies to C. jejuni
have a protective role while there is no evidence for the need for a cell mediated immune
response for recovery (17).
1.6 Physiology of C. jejuni.

C. jejuni requires a microaerobic environment for growth and this can be quite
problematic when large numbers o f organisms or their products are required. A biphasic
system has been developed which allows for the microaerobic environment to be
maintained and also supports optimal growth with a mean generation time o f 90 min
(215). However, the organism can adapt to an aerobic metabolism after being left in air
for a prolonged time. The adaptation was found to be maintained indefinitely following
subsequent passages in air (110).
Typically, C. jejuni is a slender, gram negative rod in a microaerobic environment,
but under adverse conditions such as nutrient limitation, aeration of the media or the
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presence o f free radicals, it usually assumes a coccoidal morphology (27, 110, 142).
Although coccoidal forms are usually found to be viable, prolonged exposure to these
adverse conditions may lead to a degenerative stage rather than a dormant state (27).
Changes in temperature, such as 25° C to 4° C, can also induce coccoidal formation which
has been attributed to changes in the relative amounts of the different membrane fatty
acids o f the organism (95). For instance, there was a significant increase in the amount of
16:0 and 18:0 fatty acids and a decrease in 14:0, 16:1 and 19:0 fatty acids (95).
Temperature and pH have also been shown to induce the production o f stress proteins by
the organism, leading to changes in the whole bacterial cell protein profile (269). It has
been suggested that these changes in protein profile could have an adverse effect on
adherence o f the organism to epithelial cells in vitro (131). One of these stress proteins
has been purified and identified as a GroEL-like protein and has been classified as part of
the heat shock 60 (HSP60) family o f proteins (241).
The chemotactic capabilities o f C. jejuni have been studied along with the effects
o f different substrates have on chemotaxis (100, 240). The only carbohydrate which was
capable of inducing chemotaxis is L-fucose. However, bile, mucin and several salts of
organic acids have also been shown to induce chemotaxis o f C. jejuni (100). The
chemoattractant capabilities o f I^fucose, which is found in mucin and bile, may be of
importance in the colonization o f the intestinal tract. Studies comparing the colonization
rate o f the mouse intestinal tract have been performed using non-chemotactic mutant
strains and chemotactic strains (240). Results from these studies show that chemotactic
movement is important in that the non-chemotactic strains were cleared by the mice within
48 h while chemotactic strains readily colonized the mice for much longer periods o f time.
The growth o f the organism in the presence o f bile salts has also been found to influence
the production o f peritrichous-pilus like appendages which could be a virulence attribute
o f the organism (57). Mutants deficient in these appendages were found to induce milder
symptoms in the ferret animal model (57).
20
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1.7 Molecular characterization of C jejuni.
Characterization o f C. jejuni can has been performed at a molecular level by
evaluating strains for unique membrane proteins or for variations in lipopolysaccharide
(LPS). The most common approach to evaluate the different components of the outer
membrane o f C. jejuni is by glycine or sodium lauryl sarcosinate extraction followed by
SDS-PAGE electrophoresis (119). Western blot analysis o f surface exposed proteins
using polyclonal antisera raised against whole C. jejuni revealed several proteins of
various sizes in addition to low molecular weight LPS. Many o f the physical properties o f
the proteins have been characterized (Table 1.2) and some o f the genes responsible for
their production have been cloned and sequenced.
The most immuno-dominant protein associated with C. jejuni is flagellin (92).
Upon closer examination o f the different serotypes o f C. jejuni. it was found that some
strains produce two distinct flagellin subunits, FLAA and FLAB, each o f molecular masses
o f 61.5 and 59.5 kDa respectively and both with an isoelectric point o f approximately 4.5
(92, 148). The pathogenic implications o f the two subunits have not yet been elucidated

even though the antigen has been found in several different species but can differ in
molecular weight (161). Closely associated with the flagellin protein is a 92 kDa flagellar
hook protein which is part o f the locomotion apparatus and is thought to join the flagellar
filament with the basal body ( 107, 206). The hook protein from C. jejuni has yet to be
sequenced, but analysis o f the N-terminal o f the protein, shows it to be identical to that o f
C. coli, while it possess very little homology with the hook proteins from Salmonella sp.
and Caulobacter sp. (206).
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Table 1.2. Summary o f characterized proteins from C. jejuni.

Protein

Function

Ref.
(92)
(92)
(107)

18
58
24.8

flagella protein A
flagella protein B
Join the flagellar filament to the intramembrane located
basal body
forms small channel with single channel conductance
unknown
corresponding gene is used for speciation of C. jejuni by
PCR; function of protein is unknown
unknown
unknown
potential homology with class I pili from Neisseria
meningitidis and if. coli heat-labile enterotoxin B subunit
partial homology with serine protease inhibitor
superfamily
similarity to peptidoglycan-associated lipoproteins
catalyses the dismutadon of H2 O2 to H20 and Q>
catalyses the dismutation of superoxide radicals

17.9
46

Fur-like iron-responsive genetic regulatory protein
involved in the conversion of L-glutamate to proline

(43)
(149)

binds to DNA and induces the condensation o f DNA into
bead-like structures
catalyses the covalent attachment of amino acids to the 3'
end of tRNAs
enzyme involved in leucine biosynthesis

(134)

Size

(kDa)
flagellin A(FlaA)
flagellin B (FlaB)
Hook protein

61.5
59.5
92

MOMP-porin protein
Omp30
MAPA

43
30
24

PEB-1
PEB-2
PEB-3

28
29
30

PEB-4

31

Ompl8
catalase
superoxide dismutase
(SodA)
Fur
gamma-glutamyl phosphate
reductase (ProA)
histone-like (Hup)

11

lysyl-tRNA syntheses (LysS)
p-isopropylmalate
dehydrogenase (LeuB)
RecA

40

isoleucyl-tRNA synthetase
OleS)
kanamycin
phosphotransferase
trigger fector
LcrD/FlbF
argininosuccinate lyase
(ArgH)

56

(26)
(60)
(237)
(31)
(31)
(31)
(31)
(135)
(83)
(208)

(41)
(141)
(88)

105

recognizes single stranded DNA and anneals it to a
complementary sequence in a homologous duplex
enzyme involved in aminoacylation of isoleucyl-tRNA

29

confer kanamycin resistance

(248)

56
79

thought to be involved in cell division
proteins are involved in regulation or secretion of
virulence-related proteins
cleaves argininosuccinic acid into arginine and fumarate

(85)
(157)

37
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(98)

(89)

The major outer membrane protein (MOMP) present in the cell wall o f C. jejuni has been
identified as a porin, with a calculated molecular weight of 43-kOa and has been identified
in approximately 60% o f pathogenic strains o f C. jejuni (26, 103, 118). When the
MOMP was purified and reconstituted in a lipid bilayer, it formed a channel with a
conductance of 8.82 nS in 1M KC1 (103). Conformational analysis o f the porin protein
showed it was a trimer formed by three folded monomers with a high degree of (3-sheet
secondary structure. It was also found to be immunologically similar to the OmpC protein
in E. coli (118) and has been classified as part o f the trimeric porin family (103).
Membrane proteins have also be used to identify C. jejuni from other Campylobacter sp.
as well as to distinguish between thermophilic and non-thermophilic Campylobacters (6 0 ).
Thermophilic Campylobacters contain a unique, immunologically similar 3 1-kDa protein
expressed on the surface o f the organism and this protein is absent in non-thermophiles
(60). Another surface protein has been identified and termed membrane associated protein
A (MAPA), which can help distinguish between C. jejuni and other Campylobacter sp.
The unique C. jejuni species-specific 24-kDa protein was first identified by screening a
genomic library with antisera raised against C. jejuni only. This finding led to a PCRbased technique which is specific for the mapA gene, which encodes for the specie specific
membrane protein and provides a means o f identifying the organism (2 3 7 ).
Glycine extractions have lead to the purification and characterization of several
other outer membrane proteins (OMP) (30, 31, 38, 65, 119, 154). Four such proteins are
considered to be major common antigens present on the surface of C. jejuni (31).
Originally they were referred to as cell binding fractions (CBF) (65) but have since been
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renamed FEB 1-4 (31). These proteins are basic in nature and have calculated molecular
masses o f 28-kDa (PEB1), 29-kDa (PEB2), 30-kDa (PEB3) and 3 1-kDa (PEB4) (31).
Only PEB 1 and PEB3 are capable o f eliciting an immune response in humans, making
them potential targets for vaccine development. Recently, the PEB4 protein was cloned
and sequenced and shown to be highly conserved genetically among other isolates o f C.

jejuni (31). An 13-kDa OMP has also been cloned and sequenced and shown to have
genetic homology with a peptidoglycan-assodated outer membrane lipoprotein P6 o f

Haemophilus influenzae (30). An intracellular iron-binding protein has also been purified
and characterized and found to be similar to the protein ferritin from Helicobacter pylori
and Bacteroides fragilis which are more closely related to eukaryotic ferritin than
bacterioferritin (256).
A major component o f the outer membrane o f C. jejuni is the LPS and some o f the
carbohydrate moieties present in the LPS have been characterized using nuclear magnetic
resonance (NMR). C. jejuni contains low oligosaccaharide (LOS) which can only be
detected with a modified silver staining protocol in addition to the high molecular weight
LPS containing O-side chains which can only be visualized on immunoblots using strainspecific antisera (9, 158). Two of the Penner serotypes, 0:4 and 0:19, have been found
to contain core oligosacchrides with terminal structures similar to GMi and G D ia
gangliosides present on human nerve tissues (8, 277). They also contain sialic add
residues which are typically found on glycosylated eukaryotic proteins (158). Sialic acid
residues are considered to be weak immunogens but may offer some resistance to
bacteriddal antibodies normally present in serum (158). Thin layer chromatography
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studies have shown that there are also epitopes present on the LPS from isolated strains o f
C. jejuni similar to G Q ib and GD3 ganghosides (221, 278).
Currently, little is known about the genetic structure and function o f most o f the
genes present on the chromosome o f C. jejun i since relatively few have been cloned and
sequenced successfully (244). However, the average size o f the genome as determined by
PFGE, is 1.72 Mb (44, 122,246). Mapping o f the genome using hybridization techniques
with known sequences from other bacteria allowed for the elucidation o f the genetic
organization o f several "housekeeping" genes (246). "Housekeeping" genes are those
which are highly conserved between different species o f bacteria and which can be used to
map the genome from unknown bacteria even if very little is known about the genetic
organization o f the bacterium in question (244).
Genetic studies conducted on C. jeju n i have shown it to be susceptible to the three
common genetic transfer mechanisms: transformation, conjugation and transduction (244,
248, 261, 263). The uptake of naked D N A (transformation) has been shown to occur in
C. jejuni and, although it will take up foreign D N A , it preferentially takes up its own (261,
263). This can be demonstrated by incubating C. jejuni with D N A fragments containing
the antibiotic determinant tetM, which confers resistance to tetracycline, and could explain
the increase in antibiotic resistance among some clinical isolates (261). Conjugal transfer
o f plasmids between strains of C. jejuni carrying antibiotic resistant determinants has also
been documented (244, 248). Bacteriophage transduction has been used to type C. jejuni,
but antibiotic resistance determinants (244) and potent cytotoxins (182) are known to be
carried on phage in other genera, thereby causing a change in the characteristics of the
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strain infected with the phage. C. jejuni has also been shown to exhibit recombination and

horizontal gene transfer as evidenced by variation o f the flagellar gene locus (264). This
mechanism may allow adaptation o f the organism or provide a means for it to escape the

immunological response o f the host.
A compilation o f the C. jejuni genes which have been cloned and sequenced are
summarized in Table 1.3. Many researchers have encountered difficulties with cloning and

gene expression in C. jejuni. The most common problems are failure o f the genes to be
expressed. Dispite the fact that the gene o f interest has been successfully cloned,
problems o f gene instability, cloning only a portion o f the gene o f interest and post
translational modification problems result in expression failures (244). Expression
problems could also be explained by the presence o f unusual promoters not recognized by
recipient cells or failure to process gene products as well as differences in methylation
leading to instability. The construction o f new cloning vectors has alleviated some o f the
problems and hopefully their use will lead to a better understanding o f C. jejuni genetics
(244, 271) and pathogenicity.

1.8 Immune response to C jejuni infection.
With a suitable model, it would be possible to study the pathogenic mechanisms of

C. jejuni and the immune response elicited by the host. Rabbits have not only been used
as a model for colonization but have also been used to evaluate the immune response
against selected components of the organism. For instance, both the serological typing
schemes, Lior et al. (147) and Penner et al. (160), are conducted using rabbit polyclonal
antisera against the heat-labile and somatic O antigens, respectively. Rabbits have also
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Table 1 3 . Summary o f the genes which have been cloned and sequenced from C. jejuni.
Cloning strategy

location

1.5

Reverse genetics3
XZapII and antibody

0.86

pGem and hybridization

0.5

pBluescript II SK+ and antibody

catalase (katA)

1.5

pTZ19R vector

isoleucyl-tRNA synthetase (ileS)

2.7

kanamycin resistance genes (aphA-7)

0.75

Gene cloned
DNA gyrase (gyrA)
trigger factor {tig)
ferric uptake regulatory gene (fur)
Ompl8 (om plS)

tetracycline resistance gene (let)
superoxide dismutase (sodA)

Chrom.

seq.
pub.
Yes

(2 6 0 )

Chrom.

Yes

(84)

Chrom.

Yes

(43)

Chrom.

Yes

(135 )

Chrom.

Yes

(83)

pBluescript and hybridization

Chrom.

Yes

(98)

pBR322 vector

Plasmid

Yes

(248 )

1.8

pBR322 and hybridization

Plasmid

Yes

(249 )

0.66

pTZ19R and hybridization

Chrom.

Yes

(2 0 8 )

MW
(kb)
2.6

Ref.

gamma-glutamyl phosphate reductase
(praA)
histone-like D NA binding protein
(hup)
ribosomal RNA

0.3

pBR322 and hybridization

Chrom.

Yes

(149 )

0.4

XZapK and antibody

Chrom.

Yes

(1 3 4 )

-

pBR322 and hybridization

Chrom.

No

(1 2 3 )

lysyl-tRNA synthetase (lysS)

1.5

pBR322 and hybridization

Chrom.

Yes

(41)

leucine biosynthesis genes (leu)

-

pHC79 cosmid

Chrom.

No

(1 4 1 )

flagellin (JlaAJlaB)

1.7

XGT11 and antibody

Chrom.

Yes

(1 8 0 )

cytolethal distending toxin gene
(cdtA B O
serine hydroxymethyl transferase
(glyA)
acetylomithinase (argE)

2.3

PCR and hybridization

Chrom.

Yes

(202 )

1.2

Reverse genetics3

Chrom.

Yes

(40)

-

Chrom.

Yes

(2 4 4 )

major cell-binding factor (peb4A)

0.821

Reverse genetics3
XGT11 and antibody

Chrom.

Yes

(31)

major cell-binding factor receptor

0.728

XGT11 and antibody

Chrom.

Yes

(31)

major cell-binding factor (pebl)

0.779

A.GT11 and antibody

Chrom.

Yes

(194 )

0.6

pBluescriptllSK and antibody

Chrom.

Yes

(2 3 8 )

0.577

DNA sequencing

Chrom

Yes

(31)

1.4

Reverse genetics3
-

Chrom.

Yes

(88)

-

Yes

Genb

Yes
Yes

Genb
Genb

membrane-associated protein A
(mapA)
fructose 1,6-bisphosphate aldolase
(fdaC)
argininosuccinate lyase (argH)
aspartate-semialdehyde dehydrogenase
(asd)
creB
5-enolpyruvinylshikimte-3-phosphate
synthetase (aroA)
lytB
GTP cyclohydrolase I (folE)
ATP dependent casein protease (clpP)
(partial)
transcription regulation gene (JhA)

1.13
0.2
1.28

-

-

-

-

0.83
0.637

-

-

Chrom.

Yes
Yes

Genb

DNA sequencing

0.147

DNA sequencing

Chrom.

Yes

(84)

0.845

AZapII

-

Yes

Genb
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(84)

Gene cloned

MW
(kb)
1.1

Cloning strategy

location
Chrom.

seq.
pub.
Yes

pBR322 and activity

Ref.

(89)

-

Yes

Genb
Genb

benzoylglycine amidohydrolase
(hipporicase) QripO)
high temperature required gene/serine
protease QttrA)
regX
tRNA-Leu

1.1

-

0.256
0.076

ABG51 and hybridization

Chrom.

Yes
Yes

tRNA-Iso

0.076

ASG51 and hybridization

Chrom.

Yes

tRNA-Ala

0.075

ADG51 and hybridization

Chrom.

Yes

5S rRNA

0.719

ABG51 and hybridization

Chrom.

Yes

16S rRNA

1.5

ABG51 and hybridization

Chrom.

Yes

23S rRNA

0.8

ABG51 and hybridization

Chrom.

Yes

recA

1.03

pUC18 and hybridization

Chrom.

Yes

arylsulfatase (atsA)

1.8

pYG665 vector

Chrom.

Yes

(124)
(124)
(124)
(124)
(124)
(124)
(87)
(272)

phenylalanyl-tRNA synthetase beta
chain (phHeS)
flagellar biosynthesis gene (IcrD/flbF)

0.3

-

-

Yes

Genb

2.2

pSM31 and hybridization

Chrom.

yes

(157)

26 kDa protein gene
61 kDa protein gene
histidine periplasmic binding protein
(hisJ)

0.7
1.7
0.797

-

-

-

-

-

-

Yes
Yes
Yes

Genb
Genb
Genb

-

a Reverse genetics refers to complementation o f an E. coli mutant by cloned gene(s) from

Campylobacter species (e.g. complementation o f proA and proB mutations) (244).
Genb, sequence available only through Genbank
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been used to study the antigenic nature and variations in flagella o f the organism (72, 92).
Western blot analysis using rabbit whole cell antisera raised against flagellated (F+), motile
(M+) strains showed strong reaction with the 63-kDa flagella protein which was absent
from aflagellated (F-), non motile strains (M-). It was found that the amino-terminus, the
carboxy-terminus and the center o f both FLAA and FLAB proteins are highly
immunogenic as determined by specificity studies using monoclonal antibodies (57.92.
175). These regions o f the flagella could be used as targets for serodiagnostic tests and
vaccine development especially as they have been shown to be involved in adherence of
the organism to the host (24, 268). Rabbit polyclonal anti-flagella antibody has been used
to test efficacy as a potential vaccine in rabbits. Results showed that by pretreating the
organism with the anti-flagella, colonization was drastically reduced when compared to
colonization with untreated bacteria (57).

C. jejuni was found to

stim ulate

both the mucosal and the systemic immune

systems o f infected rabbits and it was clear that humoral and mucosal immunity both play
a role in inhibiting the colonization and bacteremia that often follows subsequent exposure
to the organism (184). The mucus covering the villi in the intestine was shown to be
readily colonized by C. jejuni, except when the rabbit had been previously colonized. This
is because the secretory immunoglobulin A (slgA) present from previous infections and
the glycoprotein component present in the mucus (called mucin) inhibit binding o f the
organism to underlying cells (155). The movement o f slgA-coated bacteria in the mucus
is dramatically reduced and in conjuction with glycoproteins in the mucus, large
aggregates are formed which are then removed by normal intestinal peristalsis (155).
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Mice have also been used to study the inflammatory response and intracellular
survival o f C. jejuni (121,187). One research group showed that the organism was
phagocytized in vivo by macrophages and killed within the first 24 h following
intraperitoneal challenge of BALB/c mice (187). Contradictory results show that C. jejuni
can survive within mononuclear phagocytes for an extended period o f time, which could
be facilitated by the conversion o f the organism to a coccoidal form instead o f the
traditional rod shape (121). Mice have also been used to evaluate the vaccination o f
mature females prior to mating. Results show that greater than 50% o f the pups bom to
previously vaccinated mothers were protected from colonization when allowed to receive
their own mother's colostrum (1, 2). Protection was found to be mediated by high levels
o f anti-C. jeju n i IgG antibodies found in the mammary secretions, while IgA levels remain
lo w (l, 3).
The role o f the macrophage and complement in C. jejuni infections have been
studied by comparing the mortality rate o f mice depleted of both components (16). Mice
depleted o f macrophages following injection intraperitoneally with either silica dust,
Liquoid, or dextran sulfate, had a mortality rate of 64% compared to 25% for undepleted
control mice (16). Decomplementation o f the mice, induced by injecting cobra venom
factor intraperitoneally, had little effect on mortality, suggesting that complement may not
be important in alleviating infections (16).
The effects o f recombinant interleukin (rIL) 2, 5 and 6 on colonization o f mice
with C. jeju n i has also been investigated. Results show that rlL-5 and rEL-6 reduced the
number o f organisms shed in the feces while rIL-2 had no effect on the colonization rate
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(15). Campylobacter-specific IgA was also increased in rIL-6 treated mice as opposed to
those treated with rIL-5 and rIL-2. IL-2 treated mice were more resistant to
recolonization following subsequent challenges (15).
The majority o f humans with campylobacteriosis develop a full range o f antibodies
against antigens present on the organism as demonstrated by complement fixation,
agglutination, enzyme linked immono-sorbant assay (ELISA) and Western blot analysis
(178). Antibodies specific for C. jejuni can be detected at around 6 or 7 d after initial
onset o f symptoms and this is followed by a rapid increase in IgG, IgM and IgA levels.
Levels o f IgM and IgA peak 7 to 10 d after symptoms are first recorded but decline
rapidly while IgG levels peak at 3-4 w and remain at high levels for several months (178).
Studies o f the intestinal mucosa o f infected humans have found there is an increased local
immune response with high levels o f C. jejuni-specific slgA; however, data regarding the
role o f the cell mediated immune response at the mucosal level are not available (178).
The presence o f anti-C. jejuni flagella IgA antibodies in human breast milk has been
shown to provide passive protection against Campylobacter infections similar to that seen
in mice (1, 2, 174). This process is most important in developing countries where

Campylobacter infections are more prevalent. A number o f studies have assessed the
human immune response to C. jejuni proteins and LPS. Proteins, present in the cell wall
and ranging from 92-kDa to 14-kDa, were found to elicit an immune response. In these
studies, the flagellar proteins are the most immuno-dominant (9, 159, 189).
The human immune response to the LPS of C. jejuni has gained much attention
recently. Analysis o f human sera show that IgG, IgA and IgM molecules react with the
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LPS o f C. jejuni following exposure (25). Recent reports have indicated that individuals
with campylobacteriosis induced by 0 :4 and 0:19 Penner serotypes o f C. jejuni may be

predisposed to the type o f autoimmune response seen in Guillain-Barre syndrome (GBS)
and Miller-Fisher syndrome (MFS) (165, 25, 214). Both conditions are neuromuscular
disorders characterized by paralysis induced by demyelination o f the peripheral nerves
(210). As stated earlier, approximately 1% o f the population contract campylobacteriosis
in any given year and o f these 1-2/100,000 go on to develop GBS while o f those with
GBS 15-40% were documented as having had a preceding infection with C. jejuni (139,
276). Western blot analysis shows cross reactivity between sera from GBS and MFS
patients and the LPS from C. jejuni. Closer examination of the carbohydrate moieties
present in the LPS revealed an epitope similar to GMi ganglioside present on neural
tissues (8, 139, 275). About 50% o f patients with anti- GMi antibodies have had a recent
case o f campylobacteriosis caused by C. jejuni (101). The LPS has also been shown to
induce antibodies against GM 2, G D ia, G D ib and GTib gangliosides (210, 278). Both
features can lead to an autoimmune response against neural tissues leading to an acute
neuromuscular paralysis while 5-10% o f those inflicted with this condition die due to
complications (6).
Miller Fisher syndrome is usually considered a milder form o f GBS and is typically
characterized by external ophthalmoplegia, cerebral ataxia and lack o f tendon reflexes
(278). Patients with MFS have been found to contain high levels o f anti-GQ lb IgG
antibodies (106, 278) and most individuals who develop MFS have also had a documented
case o f campylobacteriosis prior to onset o f neurological symptoms (106). One o f the
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strains o f C. jejuni isolated from a MFS patients was shown to cross react with anti-GQib
antibodies present in their serum (278). A recent report has linked the onset o f MFS with
a case o f camplyobacteriosis caused by a strain of C. jejuni with LPS resembling
ganglioside GD3 (221). These finding supports the hypothesis that molecular mimicry
exists between C. jejuni and the neural tissues in the patients diagnosed with MFS (106,
221,278).

1.9 Pathogenic mechanisms of C jejun i
It is highly likely that C. jejuni possesses several pathogenic strategies for disease
induction. For instance, they adhere to host cells, become engulfed by the cells and
undergo intracellular replication. In addition, C. jejuni produces a range o f potent
exotoxin(s). Some strains both infect cells and produce toxins. Studies have been
conducted on the adhesion and invasion capabilities o f C. jejuni with a number of
transformed cell lines (29, 130, 132, 136, 218). Results show that clinical isolates were
more invasive than nonclinical isolates and that invasion can be reduced by pre-treating the
organism with sodium meta-periodate which oxidizes the carbohydrate moieties present
on the cell surface (132, 154). Adhesion and invasion of CaCo-2 cells by C. jejuni can
also be drastically reduced following treatment of the host cells with D-glucose, Dmannose, and D-fiicose (218). These results suggest that a carbohydrate molecule present
on the cell surface may be involved in adherence of some strains of the organism to host
cells (154).

C. jejuni attaches to M cells in the intestine and has been seen in the underlying
follicle by transmission electron microscopy (34,258). Adherence o f the organism to

33

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

extracellular matrix co m p o n en ts such as collagen, fibronectin and laminin have been
demonstrated and several o f the bacterial surface components have been evaluated for
their potential role in the adhesion process (140). The flagellin protein adhere to epithelial
cells and to mucous present in the intestine. Binding experiments were conducted in the
presence o f KCN which immobilized the flagella and resulted in an increased binding of
the organism to host cells (154). Other studies have found sim ilar results with respect to
increased adherence with flagellated, non-motile strains (177). Although flagellin
functions as an adhesion molecule, it has also been implicated in increased internalization
of the organism (82). This was demonstrated when non-motile, non-flagellated {flaA-

flaB- MOT-) strains were internalized 6 to 7-fold lower than non-motile, flagellated
(flaA+flaB+ MOT-) strains thereby suggesting a possible dual role o f flagellin in binding
and uptake (82).
Several surface proteins, along with glycine extracted CBF (PEB) membrane
proteins, are involved in adherence to HeLa and HEp-2 cells in vitro (65,119, 168). The
CBF (PEB) membrane proteins range in size from 28- to 32-kDa, and are considered
major common antigens on the cell surface. In competitive binding assays, CBF1 (PEB 1)
was found to inhibit adherence o f the organism to a greater extent than CBF2 (PEB4),
thus making it a potential target for vaccine development (119). Other proteins present on
the surface o f the organism, ranging in size from 36- to 42-kDa, isolated from an adherent
strain o f C. jejuni , also attach to host cells (38).
The invasion process was critically affected by temperature since invasion of
actively metabolizing host cells was inhibited at 4 ° C (136, 218). Pretreatment of CaCo-2
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with micrafilflment inhibitors such as cytochalasm D and vincristine, had no effect on
invasion o f INT-407 cells, suggesting that microtubule-dependent endocytosis is cell-line
specific (218) and may not be required for C. jejuni uptake. Invasion of the organism can
also be facilitated by coinfection with other bacteria (29). Coinfecting with either S.

typhimurium

0 1 E.

coli, a previously non-invasive strain could be internalized by host

cells. Intracellular survival o f C. jejuni following the invasion process has been studied by
quantifying superoxide dismutase production (199). This enzyme catalyzes the
breakdown o f superoxide radicals to hydrogen peroxide and dioxygen which is essential
for the intracellular survival o f the organism and to prevent oxidative damage to the
organism (199).
The expression o f different proteins by C. jejuni following cocultivation with INT407 cells, a human derived epithelial cell line, has also been studied (130). Protein gel
electrophoresis demonstrates an induction in protein synthesis with production of 14
additional proteins which are normally absent in organisms cultured in medium alone.
These proteins appear to be essential for the microbial internalization process. Growth of
the organism in the presence o f protein synthesis inhibitors such as chloramphenicol
followed by inoculation on to host cell monolayers prevents uptake of the organism by
host cells. However, these antibiotics do not effect adherence of the organism (130).
There is much controversy regarding the diversity and pathogenic involvement of
extracellular products produced by C. jejuni. Early studies looked at the production of
extracellular factors by C. jejuni, both in cell lysates and in supemate. From these studies,
it was found that the organism generated products that possessed leukocidal and
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hepatotoxic activity (127,129). While the hepatoxm produces lesions in the liver leading
to hepatitis in mice (127), the leukotoxin was responsible for destruction o f cell surfaces
o f intoxicated leukocytes (129). It is interesting to note that an infection with the
organism produced the same effects as the purified hepatoxic and leukocidal factors while

in the chicken embryo model o f infection, the supernatant fluid from organisms grown in
broth induced similar histopathological changes in the embryo tissue as did the organisms
(150). Some strains o f C. jeju n i produce alpha and beta hemolysins (162). Although

hemolysin production was influenced by the pH o f the media, iron and the species of red
blood cells used had no effect on the hemolytic activity o f the organism (162, 200).

C. jejuni has been studied extensively for the ability to produce an enterotoxin (47,
52, 53, 108, 115, 128, 239). Early studies used the receptor ganglioside GMi specific for
the V cholerae and E. coli enterotoxin, along with antisera raised against the enterotoxins
for detection and quantitation o f a C. jejuni enterotoxin. This cytotonic factor from C.

jejuni could be neutralized by either antisera and was capable of inducing fluid
accumulation in rabbit ligated ileal loops similar to E. coli and V. cholerae enterotoxins
(128). Subsequent studies showed the presence o f an enterotoxin capable of inducing
accumulation o f cyclic adenosine monophosphate (cAMP) in cells exposed to the toxin in
a fashion similar to E. coli and V. cholerae enterotoxins (62, 108). DNA hybridization
studies using oligonucleotides specific for the GMi binding site on the toxB gene from V.

cholerae and the heat labile toxin gene eltB ScomE. coli, demonstrated homologous
regions on the C. jejuni chromosome but no gene could be cloned or sequenced (36).
Recent studies have characterized and partially purified two proteins approximately 70-
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kDa (53, 133, 153) and 50-kDa (47) in size having immunological similarities to cholera
toxin and which are capable o f recognizing GMi (239). Studies using the rat ileal loop
and enterotoxigenic strains o f C. jejuni displayed impaired Na+ and K+-ATPases, leading
to changes in Na+ and CF transport and fluid accumulation in the lumen of the ileum (113).
This can be demonstrated with the organism or organism-free filtrate, suggesting the
production o f an extracellular enterotoxin by the organism. However, the available
information regarding the involvement o f an enterotoxin in the pathogenesis of

Campylobacter diarrhea has been disputed and remains unresolved (196, 197, 133).
The production o f one or more cytotoxins has been demonstrated and identified by
assaying the filtrate for cytotoxic activity by using a rapid dye reduction assay to screen
many different strains and serotypes of C. jejuni or by antibody blocking assays (71, 108,
151, 164, 163). The first reports showed it was heat-labile and sensitive to trypsin and
could induce cytopathic effects in a number o f different cell lines (151, 273). Further
studies showed the cytotoxin could not be neutralized by antisera raised against Shiga-like
toxin I and II or by anti-Clostridium difficile antisera and it was greater than 14-kDa in
size by gel filtration (85). Although the production o f a Shiga-like cytotoxin by C. jejuni
has been demonstrated following neutralization studies using anti-SLT-1 B subunit
monoclonal antibody, DNA hybridization studies using cloned SLT-1 genes were
consistently negative (167). The RITARD assay and experiments using partially purified
toxin implicated a protein greater than 30-kDa having the capabilities of inducing diarrhea
in the rabbit model (188). A 68-kDa cytotoxic protein, which was virulent to chick
embryos (150), has been isolated and its activity could be inhibited by pretreating host
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cells with neuraminidase and proteases, suggesting the receptor for this cytotoxin is
glycoprotein in nature (151). Another cytotoxin is closely associated with the LPS (115)
and following DEAE-cellulose column chromatography, two protein bands o f 59- and 36kDa were characterized but it is not known whether these proteins constitute toxin
subunits (166).
A third type o f exotoxin, cytolethal distending toxin (CLDT) has been partially
characterized and has recently been cloned and sequenced (109, 202). It is a slow acting,
progressive toxin, the effects o f which are best observed after 96 h in tissue culture. This
toxin has been shown to cause an increase in cAMP levels and functions like an
enterotoxin (109). Sequencing o f the intact gene revealed three open reading frames
designated cdtA, cdtB, and cdtC corresponding to proteins o f approximately 30-kDa, 29kDa and 21-kDa respectively (202). An ELISA based system, using putative CHO and
HeLa cell receptors for CLDT, has been developed for rapid identification of CLDT (14).
The roles that the diverse reported exotoxins play in the pathogenesis of C. jejuni have not
been elucidated.
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SECTION n

Isolation and characterization of a cytotoxic porin-lipopolysaccharide
complex from Campylobacter jejuni

2.1 Abstract
Campylobacterjejuni is a major cause o f acute gastroenteritis worldwide and
toxin production by organisms in the Campylobacter genus is controversial. A clinical
isolate o f C. jejuni was previously found to produce a toxin active in cell culture assays
and this strain was used for subsequent identification and characterization of a cytotoxic
porin-LPS complex. This cytotoxic complex was isolated following high performance
liquid chromatography o f crude concentrated filtrate using a combination of size exclusion
and DEAE-anion exchange chromatography. The complex had a specific activity o f 20.1

TCDso/pg protein for HEp-2 cells, 7.49 TCD50/pg protein for HeLa cells and 1.87
TCDso/pg protein for Chinese H am ster Ovary cells. The isolated cytotoxic complex was
analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis and contained a
single protein with a calculated molecular mass o f 45 kDa in addition to a high molecular
weight carbohydrate moiety identified after staining with silver and periodic acid Schiff
respectively. The complex gave a positive Limulus amebocyte lysate test, suggesting that
the co-purifying carbohydrate was lipopolysaccharide with specificity for
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lectins Galantkus nivalis agglutinin (GNA), Maackia amurensis agglutinin (MAA) and

Datura stramonium agglutinin (DSA) but not for Sambucus nigra agglutinin (SNA) or
Peanut agglutinin. The cytotoxic activity associated with the complex was heat labile at
70°C, resistant to inactivation with trypsin and retained activity after treatment with
sodium meta-periodate and the glycosidases neuraminidase and N-glycosidase F.
Sequencing o f the N-terminus o f the protein component o f the complex revealed a 97%
homology with the major outer membrane porin protein from C. jejuni. The cytotoxic
activity o f the complex was neutralized by polyclonal, homologous antisera which reacted
on Western blot with the 45-kDa protein. The cytotoxic activity was not neutralized by
polyclonal antisera raised against a number o f previously recognized bacterial toxins
including Escherichia coli verotoxin types 1 and 2, C. jejuni and E. coli cytolethal
distending toxin, Vibrio cholerae enterotoxin and Clostridium difficile cytotoxin.
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2.2 Introduction
Campylobacterjejuni is a major cause o f bacterial-induced gastroenteritis in both
developed and developing countries. Active surveys conducted in the United States have
estimated the incidence o f gastroenteritis associated with C. jejuni to be in the order o f 1
case per 100 o f the population and this corresponds to approximately 2.5 million cases per
year (230). This estimated rate is twice that reported for salmonellosis and four times that
for shigellosis (242). Although campylobacteriosis can persist for up to 7 days, most
cases are self-limiting and only occasional instances require antibiotic and rehydration
therapy for effective treatment.
M ech anism s

o f pathogenesis in C. jejuni infections remain controversial. The

organism has been reported to be invasive and to express pathogenicity in a manner similar
to other enteric pathogens such as Yersinia (203) and Shigella (273). In addition, toxic
mechanisms have also been suggested, with a variety o f toxins having been implicated and
described (225, 259). One such toxin from C. jejuni is an enterotoxin with serological and
ganglioside-recognition properties sim ilar to that produced by Vibrio cholerae (1 1 5 , 239).

C. jejuni produces another distinctive toxin, the cytolethal distending toxin (CLDT) which
induces slow and progressive cytological changes in Chinese hamster ovary (CHO) cells
and other cells including Vero, HEp-2 and HeLa (109, 202). The CLDT gene has been
cloned and sequenced, revealing three open reading frames designated cdtA, cdtB and

cdtC encoding for 30-, 28- and 19- kDa proteins respectively (202). Expression studies
showed that all three genes must be present for the production o f active CLDT (202) and
the role o f this toxin in pathogenesis has yet to be established.
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The production o f other cytotoxins has also been described (85, 108, 115, 150,
151,166) and some have been partially characterized (151, 166). Little is known
regarding the structure and function o f these cytotoxins but, in general, they are reported
to be heat-labile, sensitive to trypsin degradation, and greater than 14 kDa in size as
determined by size exclusion column chromatography (85). Cytotoxic activity is also
associated with the lipopolysaccharide (LPS)-rich fraction o f the organism (166) but
currently the role LPS plays in the toxic response is unkno w n . Despite numerous reports
in this subject area, little is known about the role played by exotoxins in Campylobacter
disease; indeed, it is probable that a combination of virulence factors act in concert to
realize the full pathogenic potential o f these organisms.
Porins are an integral part o f the cell membrane which permit free exchange of
material between the bacterial cell and the external environment (176, 267). They usually
exist as p-barrels with 3-strands that traverse the membrane and form channels with a
diameter range o f approximately 1 run (176) and a size exclusion range o f 600 kDa to
5000 kDa (267). Porins activate splenocytes (235) and IL -1 and IL-6 gene expression in
human monocytes (76). Isolated porins from Salmonella typhi stimulate a protective
immune response in rabbits by the induction of lymphokines leading to the activation o f Tcells (80).
The major outer membrane protein (MOMP) present in the cell wall o f C. jejuni
has been identified as a porin, with a calculated molecular weight o f 43 kDa and its
presence identified in approximately 60% of pathogenic strains o f C. jejuni (26, 31, 118).
When the MOMP was purified and reconstituted in a lipid bilayer, it formed a channel
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with a conductance o f 8.82 nS in 1M KC1 (103). Conformational analysis o f the porin
protein showed it was a trimer formed by three folded monomers with a high degree o f 13sheet secondary structure (26). It is also immunologically similar to the OmpC protein in

Escherichia coli (118) and classified as part o f the trimeric porin family (103).
I report the identification and characterization o f a cytotoxic porin-LPS complex
produced by C. jejuni. Although there have been several previous reports reviewed by
Sears and Kaper (225) and Wallis (259) describing the production o f cytotoxins by C.

jejuni, the present report is the first to identify a complex composed o f a porin protein and
LPS. These findings may lead to a more comprehensive understanding o f toxin-mediated
enteritis in Campylobacter infections.

2.3 Materials and Methods
2.3.1 Bacterial strains and culture media.
Strain 2483 o f C. jejuni was isolated from a patient with gastroenteritis and was
characterized as Lior serotype 82, biotype 1 and Penner serotype 0 : 11. The organism
was passed twice on tryptic soy agar containing 5% sheep blood (TSA) following isolation
from the patient and was subsequently stored at -70°C in tryptic soy broth containing 5%
sheep blood. Thawed aliquots were cultured on TSA with 5% sheep blood prior to
inoculation into Brucella broth (BBL, Cockeysville, MD) pre-equilibrated in an
atmosphere containing 5% O2, 10% CO2 and 85% N 2. For batch preparation, a
suspension o f the organism was made equivalent in density to a McFarland number 8
standard and inoculated into 41 o f Brucella broth at a rate o f 2 ml/1. Inoculated broths
were incubated under stationary conditions in the gas mixture for 48 h at 37°C.
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2.3.2 Isolation of cytotoxic complex.
Bacteria were harvested by centrifugation at 12,000 x g for 20 min at 4°C and the
4 liters o f organism-free filtrate were concentrated by ultrafiltration at 4°C with a stirred
cell apparatus using a YM30 membrane (30,000 NMWL) (Amicon, Beverly, Ma). The
filtrate was initially concentrated approximately 40-fold by ultrafiltration and further by the
addition o f ammonium sulfate to 80% saturation at 4°C. The ammonium sulfate
precipitated proteins were collected by centrifugation at 12,000 x g for 30 min and
resuspended in 50 mM Tris-HCl buffer, pH 7.0. Purification of the cytotoxic protein was
performed using a Hewlett Packard 1050 series high performance liquid chromatograph
(HPLC) equipped with a diode-array detector. Purification was initiated by adding
concentrated filtrate at 1% o f the total bed volume to a HGLoad™ 16/60 Superdex™ 75
sizing column (Pharmacia Biotech, Uppsala, Sweden) and eluting with phosphate buffered
saline, pH 7.0 (PBS) at a flow rate o f 1 ml/min. Fractions were collected on a Gilson
fraction collector and 50 pi o f each were evaluated for cytotoxic activity using HEp-2,
HeLa and CHO cells. The molecular mass o f the native cytotoxic complex was
determined by calibrating the column using low molecular weight standards (Pharmacia
Biotech) dissolved in PBS. Cytotoxic-containing fractions were pooled, concentrated
using Centraprep-30 units (Amicon), and applied to a 7.5 X 75 mm TSK DEAE-5PW
column (Pharmacia Biotech). Proteins were eluted using a linear gradient of 0.2-0.25 M
NaCl in 50 mM Tris-HCl, pH 7.0 at a flow rate o f 1 ml/min. Fractions were collected,
desalted by spin dialysis using Centricon-30 units (Amicon) and 50 pi o f each sample were
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applied to monolayers o f HEp-2, HeLa and CHO cells for assessment o f cytotoxic
activity.
The bacterial pellet removed from the filtrate was placed on ice and sonicated
using a Bronson Sonifier 450 sonicator (Branson Ultrasonic Corporation, Danbury, CT),
centrifuged at 12,000 X g for 10 min and the supernatant fluid assayed in the same manner
as the filtrate.

2.3.3 Polymerase chain reaction.
Genomic DNA was isolated from C. jejuni strain 2483 by standard procedures
(222). PCR was conducted as outlined previously (204) using 50 ng o f genomic DNA
with is. coli verotoxin V T la primers (GAAGAGTCCGTGGGATTACG) and VTlb
(AGCGATGCAGCTATTAATAA) and VT2a (TTAACCACACCCACGGCAGT) and
VT2b (GCTCTGGATGCATCTCTGGT) at 42°C, 45°C, and 50°C annealing
temperatures. PCR was also conducted using primers DZ3 (AGTAAGGAGAA
ACAATGA) and R009 (AATAAGCCTTAGAGTCTTTTTGGAATCC) specific for

Helicobacter pylori cagA and primers F6 (GCTTCTCTTACCACCAATGC) and R20
(TGTCAGGGTTGTTCACCATG) specific for H. pylori vacA gene as outlined previously
(270). The H. pylori Penner reference serotypes 05 and 06 were used in PCR reactions as
positive controls for the cagA and vacA respectively. The PCR methodology used was as
described for cagA (270) except that 100 ng/reaction of chromosomal DNA were used for
amplification o f the vacA gene using 35 cycles o f 95°C for 1 min, 58°C for 1 min and
72°C for 2 min with a final extension o f 10 mm PCR reactions were electrophoresed on a
1% agarose gel in Tris-acetate, EDTA-containing buffer (pH 8.3) (222), stained with
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ethidiumbromide and visualized on a transilluminator (Ultra-violet Products, Inc., San
Gabriel, CA).

2.3.4 Cytotoxic activity and protein determination.
The amount o f protein at each stage o f the isolation procedure was quantified
using the BCA protein assay (Pierce, Rockford, IL). HEp-2, HeLa and CHO cells were
grown in T-75 cell culture flasks (Costar, Cambridge, MA) using Eagle’s minimal essential
media (MEM) supplemented with 10% fetal bovine serum (FBS) (Sigma, St. Louis, MO).
Cells were subcultured into 96-well plates (Costar) 24 h prior to determination o f
cytotoxic activity. Cytotoxic activity was quantified in the three cell lines as described
previously (109) and activities expressed afier 48 h incubation as tissue culture dose 50
(TCDso). A TCD 50 was defined as the amount o f toxin required to cause cytotoxic
changes in 50% o f the cells. Cell cultures were fixed for

10

min in absolute methanol and

stained for 30 min with Giemsa (Gibco BRL, Grand Island, NY). The specific activities
were determined at each step o f the isolation and expressed as TCDso/pg o f protein. E.

coli 0157:H7 strain LCDC 3787 (H19), positive for VT1, and strain LCDC 90-2380,
positive for VT2, were used as controls for TCD50 determination in HEp-2 and HeLa
cells. V. cholerae 01, strain 755, an enterotoxin-producing isolate, was used as a control
in the CHO cell assay.
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23.5 Molecular weight and physical characterization of the cytotoxic complex.
One pg o f the isolated cytotoxic material was mixed with equal volumes o f 2X
sample buffer containing (3-mercaptoethanol and sodium dodecyl sulfate (SDS) (222).
The sample was boiled for 5 min and separated by sodium dodecyl sulfate polyacrylamide
gel electrophoresis (SDS-PAGE) on a 12% homogeneous gel along with low molecular
weight standards and silver stained using a commercial kit (BioRad, Hercules, CA). One
pg aliquots o f the isolated cytotoxic material were either heated at 70°C for 30 min or
treated with trypsin in PBS at concentrations ranging from 0.03 to 1.25% for 2 h at 37°C.
Residual trypsin activity was inactivated by addition of an equal volume o f 20% FBS for 1
h at 37°C. Heated and trypsin-treated samples were serially diluted 2-fold in PBS prior to
cell culture assay to determine the degree o f activity remaining after the treatments. Heatinactivated trypsin and FBS alone were used as negative controls.

2.3.6 N-terminal sequencing of cytotoxin.
The cytotoxic component was isolated and denatured with SDS and (3mercaptoethanol and electrophoresed along with kaleidoscope prestained molecular
weight standards (BioRad) on a 12% gel SDS-polyacrylamide gel electrophoresis
(PAGE). Following electrophoresis, the protein and standards were electrophoretically
transferred to polyvinylidene diftuoride (PVDF) (BioRad) for 18 h at 100 mA in 10 mM 3[cyclohexylamino]- 1-propanesulfonic acid (CAPS) (Sigma) buffer, pH 11.0 containing
10% methanol as previously described (145). Following transfer, the blot was stained
with 0.1% Coomassie blue R-250 (BioRad) in 50% methanol for 5 min and destained with
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5 0 % m e th a n o l

and

10%

acetic acid. The immobilized cytotoxic protein was excised from

the PVDF and sequenced by Edman degradation on an Applied Biosystems model 473A
protein sequencer (CHUL Research Center, Sainte-Foy, Quebec, Canada). Protein
analysis was performed using Lasergene (DNAStar, Madison, WI).

23.7 Neutralization and Western blot analysis.
Neutralization studies were performed on 1 pg aliquots o f the isolated complex
using polyclonal antisera raised against the cytotoxic complex from C. jejuni (lot #2667),
as well as against E. coli VT1 (lot# 3075), E. coli VT2 (lot# 3076), CLDT from C. jejuni
(lot# 2539) and CLDT fro m £ coli (lot# 2523) (109), enterotoxin from V cholerae
(Sigma, lot# 114H4801) and the cytotoxin from C. difficile (Techlab, Blacksburg, Va,
lot# 1094007). Normal rabbit serum was used as a negative control. Homologous
antiserum was raised by intram uscular inoculation o f New Zealand white rabbits with 0.5
ml o f a 5 pg/ml preparation o f isolated complex emulsified in 0.5 ml Freund's incomplete
adjuvant. This was followed at weekly intervals for 4 weeks by subcutaneous injection of
the same antigen preparation in Freund’s incomplete adjuvant. Al : 1 0 dilution o f each
antiserum was added to serial two fold dilutions o f 1 pg o f the isolated protein. Alter a 1
h incubation at 37°C, aliquots o f each were added to HEp-2 cells and incubated for 48 h at
37°C. Each antiserum was also assayed using Western blot analysis. C. jejuni cytotoxic
complex, E. coli VT1 and VT2, C. jejuni CLDT, E. coli CLDT, C. difficile cytotoxin and

V cholera enterotoxin were each separated on SDS-PAGE gels along with kaleidoscope
prestained molecular weight standards (BioRad) and transferred to 0.2 pm pore size
PVDF membranes for 18 h at 100 mA. Membranes were washed with 5% skim milk for 1
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h to prevent non-specific binding o f the antibodies and then washed 3 times for 5 min each
with PBS. A 1:500 dilution o f each o f the antisera in a 1% skim milk solution containing
0.05% Tween-20 was prepared and added to the membranes for 2 h at room temperature.
This was followed by a 1 h treatment with 200 mU/ml o f goat anti-rabbit alkaline
phosphatase conjugated antibody (Boehringer Mannheim, Laval, Quebec, Canada) at
room temperature. Membranes were developed using 5-Bromo-4-chloro-3-indolylphosphate (BCIP) and nitro blue tetrazolium (NBT) (Boehringer Mannheim).
Western blot analysis was also performed on crude concentrated filtrates from C.

jejuni strain 2483, C. jejuni strain 3969, C. jejuni strain 16336, C. coli strain 8682,
Aeromonas veronii strain A2297 and E. coli (VT1+) strain 3787 (19). The filtrates from
A. veronii and E. coli were used as negative controls. A total o f 40 pg of each crude
filtrate was electrophoresed and transferred to PVDF as stated previously and probed with
anti-cytotoxic complex from C. jejuni strain 3969 (lot #2667). In addition, each filtrate
was tested for cytotoxic activity in HEp-2 cells after 48 h o f incubation.

2.3.8 Carbohydrate characterization.
A total o f 2 pg o f the isolated cytotoxic material was assayed for the presence of
lipopolysaccharide by the Limulus amebocyte lysate (LAL) test according to the package
insert (Pyrotell, Associates o f Cape Cod, Inc., M A). The toxic material was diluted 10fold with pyrogen free water in duplicate and 100 pi o f each dilution were incubated with
100 pi o f Pyrotell in a 37°C water bath for 1 h. Tubes were inverted and those containing
a solid clot were considered positive. To determine whether the lipopolysaccharide
contributes to the activity o f the toxin, 1 pg o f the isolated cytotoxic material was
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incubated for 1 h at 37°C with 5 U neuraminidase (Sigma) at pH 5 .0 , 3 U of Nglycosidase F (Boehringer Mannheim) at pH 7.2 and 10 mM sodium meta-periodate
(Sigma) for 90 min at room temperature. The residual cytotoxic activity was then assayed
in HEp-2 and HeLa cells using serial two-fold dilutions. Identification o f the carbohydrate
moiety was made using a glycan differentiation kit (Boehringer Mannheim) containing five
unique digoxigenin-labeled lectins (Table 2.1). Approximately 1 pg o f the isolated
cytotoxic protein and 5 pg o f each carbohydrate standard were spotted on PVDF
membranes and allowed to dry overnight at 37°C. Membranes were probed for the copurifying LPS according to the manufacturer’s instructions. Those lectins that gave
positive results were further examined by Western blot analysis using 15 pg of each
carbohydrate standard and 8 pg o f the test carbohydrate from the purified preparation.
The isolated cytotoxic material from three separate batches was assayed for carbohydrate
concentration using a phenol-sulfuric acid assay measured at 4 9 0 nm (5 9 ). The
concentration o f carbohydrate in pg was determined and expressed as a ratio for each pg
o f purified protein in these preparations. SDS-PAGE and native PAGE were performed
using 10 pg o f the carbohydrate and gels were double stained, first with periodic acidSchiff (PAS) (226) then with Coomassie blue.

2.4 Results
2.4.1 Identification a n d molecular characterization of cytotoxic complex.
Early cytological signs o f intoxication caused by the cytotoxic complex included
the formation o f vacuoles in the cytoplasm of both HEp-2 and HeLa cells. The number o f
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Table 2.1. Specificities and the reactions o f the lectins used in the carbohydrate determination.

Lectins

Specificity (linkage)

Galanthus nivalis agglutinin (GNA)

M ana(l-3), a (l-6 ) or a (l-2)-Man
(terminally linked mannose)

Maackia amurensis agglutinin (MSA)

Neu5Aca (2-3)-Gal (sialic acid terminally
linked a2-3 to galactose)

+

Datura stramonium agglutinin (DSA)

Gaip( l-4)GlcNac (galactose-P( l-4)-Nacetylglucosamine)

+

Arachis hypogaea (peanut) agglutinin (PNA)

Gaip(l-3)GalNac (galactose-P(l-3)-Nacetylgalactosamine)

-

Sambucus nigra agglutinin (SNA

NeuSAca (2-6)-Gal or GalNac (sialic acid terminally
linked a(2-6) to galactose or N-acetylgalactosamine)

* +++ strong positive result
+ weak positive result

Reactivity*
+++

-

vacuoles in each cell ranged from 1 to 5 with 50% or more o f the cytoplasm o f some cells
hemg affected. After 24 h, the vacuoles diminished in size and the cells developed a
rounded, highly refractile appearance. Over the course o f the subsequent 24 h (i.e., from
24 to 48 h), cytoplasmic blebbing and nuclear condensation become more evident along
with cell loss from the monolayer. Toxicity appeared to be dose-dependent and was
detected using 2-fold serial dilutions o f the isolated material (Fig 2.1) At the lower
cytotoxin concentration o f 1 pg o f protein/well (Fig 2. IB), the vacuoles persisted up to 48
h while rounding occurred up to 72 h as compared to the control (Fig 2.1 A) When higher
cytotoxin concentrations o f 10 pg protein/well were used; vacuoles formed and dissipated
within the first 12 h following intoxication and greater than 50% of the cells were rounded
and refractile by 24 h. By 48 h, 80-100% of the cells had become rounded (Fig 2.1C).
Similar cytological changes were observed in all o f the cell lines when the whole bacterial
cell sonicate was assayed for toxicity. Strain 2483 produced low levels of CLDT in the
crude concentrate in the fractions from the G75 column purification, however this could
be neutralized with polyclonal antisera raised against C. jejuni and E. coli CLDT (data not
shown). However, no residual CLDT activity was observed in the DEAE purified
fraction.
The organ ism s were grown for 48 h at 37°C in Brucella broth at which time the
bacteria were in the stationary growth phase as determined by viable colony counts.
Concentrated proteins possessing high levels o f cytotoxic activity were found to elute
from the G75 column in the void volume (Fig 2.2, peak A) with a calculated native
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*
Figure 2.1.
Morphological changes induced in HEp-2 cells after 48 h treatment with C. jejuni
cytotoxic porin-LPS complex. (A) control (magnification 85X); (B) 1 pg o f isolated C.

jejuni cytotoxic complex (magnification 85X); (C) 10 pg o f isolated C. jejuni cytotoxic
material (magnification 80X ). Insert is of a single HEp-2 cell (magnification 175X).
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molecular mass o f greater than 100 kDa. This peak was collected and applied to the TSK
DEAE-5PW column. Cytotoxic activities o f the TSK DEAE-5PW fractions showed the
toxin eluted at approximately 0.21-0.22 M NaCl (Fig 2.3). The two-column purification
procedure produced a single silver-stained protein with a molecular size o f 45 kDa
calculated by R/ under denaturing conditions (Fig 2.4). The specific activities at each
stage o f the purification procedure are shown in Table 2.2. The isolated cytotoxic
complex had the highest specific activity in HEp-2 cells and the lowest in CHO cells. The
cytotoxin w as inactivated by heat treatment at 70°C for 30 min but was resistant to trypsin
at the concentrations tested.
Oligonucleotide primers specific for £. coli VT1 and VT2 failed to produce
amplicons corresponding to A- and B-subunits o f mature verotoxin types 1 and 2 at the
various annealing temperatures. Also, primers specific for the cagA and vacA genes o f H.

pylori failed to generate amplicons.

2.4.2 Protein Alignment.
The cytotoxic protein-LPS complex consisted o f a single protein with a calculated
molecular mass o f 45 kDa. The excised band w as subjected to N-terminal sequencing and
a total o f 31 ammo acid residues were elucidated (Table 2.3). The protein was found to
contain several hydrophobic and charged residues and had a predicted isoelectric point o f
4.35. The protein had 97% homology with the major outer membrane protein (MOMP)
from C. jejuni which has been characterized as a porin (26) and the single amino acid
difference at residue 30 was conserved. The cytotoxic porin also shared 56% and 63%
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Figure 2.2.
Elution profile o f the cytotoxic complex. (A) Am m onium sulfate precipitated
proteins were applied to a G75 gel filtration column and cytotoxic activity was found in
the void volume. +++, >70% cell rounded by 48 h, ++ 50-70% cell rounded by 48 h, +,
<50% cell rounded by 48 h
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Figure 2.3.
Peak A from the G75 column was collected and applied to TSK DEAE-5PW
column and eluted with a linear gradient o f NaCl from 0.2 M to 0.25 M and cytotoxic
activity was found in peak. +++, >70% cell rounded by 48 h.
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1

3

2

Figure 2.4.
Silver stained SDS-PAGE after TSKDEAE-5PW column. Lanes 1 and 3: low
molecular weight standards (kDa) (BioRad); Lane 2: 1 pg o f C. jejuni isolated cytotoxic
porin-LPS complex.
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sequence homology with 45 kDa and 51 Kda outer membrane proteins respectively from

Wolinella recta (117).

2.4.3 Neutralization and Western blot analysis.
Polyclonal antisera raised against E. coli VT 1 and VT 2, C. jejuni and E. coli
CLDT, V cholerae enterotoxin and C. difficile cytotoxin failed to neutralize the cytotoxic
effects elicited by the C. jejuni toxic complex in cell culture. However, when this
cytotoxic complex was serially diluted, incubated with homologous rabbit polyclonal
antiserum and added to HEp-2 cells, the TCDso was 1:2 whereas cytotoxin incubated with
normal rabbit serum had a TCDso o f 1:32. Neutralization was defined as a decrease in the
TCDso at 24 h post-intoxication. Homologous antiserum also showed immunological
reactivity with the purified 45 kDa cytotoxic protein but not with the high molecular
weight carbohydrate component. Antisera raised to the other toxins showed no cross
reactivity with either the cytotoxin or carbohydrate on Western blot analysis (Data not
shown). Western blot analysis using crude concentrated filtrates from various cytotoxic
strains of Campylobacter sp and antiserum raised against the porin-LPS complex, revealed
an immunologically similar protein with a molecular mass comparable to that o f the porin
(Fig 2.5). However, this immunologically similar protein was not present in filtrates o f A.

veronii and E. coli.

2.4.4 Lipopolysaccharide identification and carbohydrate analysis.
The isolated cytotoxic material was assayed for the presence o f endotoxin by
incubating serial dilutions with Limulus amebocyte lysate for 1 h at 37°C. The cytotoxic

58

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Table 2.2. Specific activities expressed as TCDWug o f protein at each step o f the isolation
procedure for the cytotoxic complex from C. jejuni and the toxin control strains in HEp-2,

HeLa and CHO cells.

Tissue Culture Cells
Specific Activity*
Toxin Preparation
HEp-2

HeLa

CHO

C jejuni crude concentrate

1.56

0.51

0.51

C jejuni Superdex 75 16/60

1.61

3.88

0.97

C jejuni TSK DEAE-5PW

20.1

7.49

1.87

E. coli VT1+

0.35

0.17

ND

E. coli VT2+

1.48

2.89

ND

V cholerae O l

ND

ND

0.48

* TCDso/pg o f protein
N D not determined
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Table 2.3. Sequence homology o f the C. jejuni 2483 cytotoxic protein and other sequence
available in BLAST; (Beckman Center for Molecular and Genetic Medicine, Stanford
U niversity

changes;

o f Medicine). Capital letters represent identical residues; “*” represent conserved
represents mismatch in sequences; “X” represents unknown residue.

Protein designation

Sequence

Ref

C. jejuni cytotoxic protein

TPLEEAIKDVDVSGVLRYRYDTGNFDKNFVN

C. jejuni MOMP; porin protein

TPLEEAIKDVDVSGVLRYRYDTGNFDKNF*N

W. recta 45 kDa OMP

T P L E E A IK D V D -S G ------Y X Y - * - - - X - N - -

(19)

W. recta 5 1 kDa OMP

T P L E E A IK * V D * S G - -X Y X Y * ---------- K N- -

(19)
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Figure 2.5.
Western blot analysis using antiserum against the porin-LPS complex with 40 pg
o f crude, concentrated filtrate from Campylobacter sp. Lanes 1 and 9: Prestained
standards (kDa) (Gibco BRL); Lane 2: uninoculated broth; Lane 3: Aeromonas veronii
strain A2297; Lane 4: C. coli strain 8682; Lane 5: C. jejuni strain 16336; Lane 6: C.

jejuni strain 3969; Lane 7: C. jejuni strain 2483; Lane 8: E. coli (VT1+) strain 3787.
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material produced a strong positive result at a dilution o f 1:128,000 signifying that the
isolated cytotoxic material contained LPS. To determine which part o f the complex was
responsible for the cytotoxic activity observed in tissue culture, the complex was
incubated with 10 mM sodium meta-periodate, to oxidize the free hydroxyl groups present
on visceral hexoses, with 5 U neuraminidase, to cleave sialic acid residues and with 3 U N glycosidase F to cleave asparagine bound N-glycans. The complex was then assayed for
cytotoxic activity in HEp-2 and HeLa cells. Titers o f 1:32 were observed for each o f the
test wells in HEp-2 cells while a titer o f 1:8 was found for each of the wells in HeLa cells
which were both equivalent to the control w ell The difference in toxicity titers observed
between the HEp-2 and HeLa cells was consistent with previous findings by McSweegen
and Walker (154).
The carbohydrate component of the LPS was characterized using digoxigeninlabeled lectins (Table 2.1) and the data revealed a complex of different subunits. Lectin

Galanthus nivalis agglutinin (GNA) reacted strongly with the purified material and
suggested a high proportion o f terminally-linked mannose. The lectins Maackia

amurensis

agglutinin

(MAA) and Datura stramonium agglutinin (DSA) also gave positive

but weaker results, indicating the presence o f sialic acid terminally linked a(2-3) galactose
and galactose-P(l-4)-N-acetylghicosamine in the complex as well as hybrid N-glycan
structures. The remaining lectins showed no reactivity for the carbohydrate complex. The
proportion o f carbohydrate to protein in the purified material was calculated at a ratio of
4:1. PAS staining revealed a high molecular weight carbohydrate which did not appear as
a discrete band as did the protein component o f the complex but, instead, occupied a
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broad range o f sizes (Fig 2.6). Double staining o f purified cytotoxin in native PAGE gels
showed no protein component (Fig 2.7, lane 2) in contrast to samples boiled in denaturing
buffer prior to gel electrophoresis (Fig 2.6, lane 3) showing the importance o f denaturing
the sample prior to electrophoresis in order to resolve the protein component o f the
complex. Western blots performed with the lectins showed that the high molecular mass
smear seen following PAS staining (Fig 2.7) was carbohydrate in nature with high
reactivity for GNA (Table 2.1).

2.5 Discussion
A cytotoxin from strains o f C.jejuni that was heat-labile, trypsin-sensitive and
induced rounding o f HEp-2, HeLa and MRC-5 cells was first documented by Yeen et al.
(273). Guerrant et al. (85) also described a cytotoxic component which was heat labile at
60°C, was partially sensitive to 0.25% trypsin and had a molecular weight greater than 14
kDa. The cytotoxic component identified by these workers could not be neutralized using
antisera raised against E. coli verotoxins or C. difficile toxin (85). A subsequent report
indicated the presence o f a Shiga-like cytotoxin from C.jejuni which could be neutralized
with monoclonal antibodies directed against the B subunit o f the mature Shiga-toxin;
however, these workers also detected a cytotoxin which could not be neutralized by the
same monoclonal antibody (167). In addition, Guerrant and colleagues (85), unlike Yeen

et al. (273), found cytotoxic activity in sonicated whole bacterial cell preparations. In the
present study cytotoxic activity was detected in both culture and sonicated filtrates from
whole bacterial cells.
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Figure 2.6.

Double staining ofnative-PAGE and SDS-PAGE with periodic acid SchifF(PAS)
and Coomassie blue to detect the carbohydrate moieties and the protein component o f the
C. jejuni isolated cytotoxic porin-LPS complex. Lane 1: native low molecular weight
standards; lanes 2: 10 pg o f carbohydrate co-purifying with C. jejuni isolated cytotoxic
porin-LPS complex run under native conditions; Lane 3: 10 pg o f carbohydrate copurifying with C. jejuni isolated cytotoxic porin-LPS complex run under denaturing
conditions: Lane 4 :. kaleidoscope prestained standards (kDa) (BioRad);
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Figure 2.7.
Western blot analysis o f the isolated cytotoxic complex with the lectin GNA.
Lanes 1 and 4: kaleidoscope prestained standards (kDa) (BioRad); Lane 2: 10 pg of
carbohydrate co-purifying with C. jejuni isolated cytotoxic porin-LPS complex; Lane 3
15 pg carboxypeptidase Y.
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Ia the preseat study, a cytotoxic complex containing a porin and LPS was isolated and
characterized. Previous studies showed a cytotoxic factor present in LPS-rich fractions
from C. jejuni (166); however, it was not known what role the LPS played in toxicity.
Currently, no N-terminal sequence information is available from any o f the published
cytotoxins produced by C. jejuni. As a consequence, an accurate comparison cannot be
made concerning the nature o f the cytotoxin other than to define the morphologic changes
induced in cell culture and the susceptibility to trypsin and heat treatments. Misawa et al.
(163) found that the expression o f their cytotoxin was elevated when the C. jejuni was

grown in Brucella broth. However, contrary to the findings o f these workers, it was
determined here that HEp-2 cells showed the highest sensitivity to the cytotoxic complex
and that these activities were consistently higher whether or not the cell cultures were
grown in media supplemented with FBS (163). The increase in activities observed in the
different cell lines could be due to the relative amounts o f the receptor required for binding
o f the porin-LPS complex. Reports have implicated LPS in adhesion of C. jejuni to
epithelial cells which could be inhibited by periodate oxidation (154). Since the cytotoxic
activity o f the porin-LPS was maintained following treatment with periodate in both HEp2 and HeLa cells, it would appear that adhesion of the toxic complex is facilitated by
components other than LPS. It is possible that expression o f the porin protein may be
involved in binding the organism to host cells; however, Fauchere et al. (65) indicated that
the MOMP was not involved in adherence to HeLa cells. From these studies it would
appear that, although the LPS mediates attachment o f organisms to host cells (154), the
porin component binds the cytotoxic complex.
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Although the mode o f action o f the cytotoxic porin remains unclear, the
moiphological changes induced by it are similar in nature to other well-characterized
bacterial cytotoxins. During early stages o f intoxication the cytotoxic porin induced
vacuole formation in HEp-2 and HeLa cells and this was similar in appearance to those
produced in response to Helicobacter pylori vacuolating toxin (265). Although
vacuolation following intoxication with C. jejuni cytotoxin has been reported in
hepatocytes (163), no PCR products were generated with primers specific for cagA and

vacA genes suggesting that the genes encoding for the vacuole induction by the C. jejuni
porin are unique from the genes carried and expressed in H. Pylori.

When intoxication o f host cells with the C. jejuni cytotoxic porin was extended
beyond 24 h, vacuoles dissipated while the cytoplasmic blebbing and nuclear condensation
typical o f verotoxin and diphtheria toxin became more evident. Verotoxin and diphtheria
toxin are both known to interfere with protein synthesis leading to programmed cell death
or apoptosis (45, 105). PCR-based screening o f C. jejuni using verotoxin-specific primers
was negative and confirmed the low stringency hybridization experiments o f Moore et al.
(167) which suggest that the C. jejuni cytotoxic complex was distinct from verotoxin.
This cytotoxic complex was able to induce DNA fragmentation in HEp-2 cells indicating
that cells could be apoptotic. However, this presentation did not occur in Vero cells. It is
possible that the porin from C. jejuni induces holes in the cell membrane in a manner
similar to that resulting from Staphylococcus aureus a-toxin (45). This latter toxin has
also been shown to induce an apoptotic reaction. Recently, the cytotoxic effects elicited
by S. typhimurium porin suggested that porins directly effect the cytoskeleton and the
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membrane ultrastructure o f HEp-2 cells (54). In addition, porins from Neisseria sp. have
also been shown to inhibit polymerization o f actin in human neutrophils (23) while porins
from S. typhimurium have been found to induce both an inflammatory response (77) and
the release o f cytokines from human monocytes and lymphocytes (75).
Attempts to determine the isoelectric point o f the cytotoxic protein by Coomassie
blue staining and probing by Western blots o f isoelectric focusing (IEF) gels with antisera
raised against the complex were unsuccessful. This could be due to the tight complex
formed between the protein and LPS which could not be disrupted with the non-ionic
detergent, Nonidet P-40. Isolation o f the cytotoxic porin protein using a
chromatofocusing column and polybuffer 7-4 (Pharmacia Biotech) was difficult to
reproduce due to probable interference from LPS as well. The isolation protocol was also
applied to a cell-free filtrate from C. jejun i strain 3969 which had previously been reported
to produce a cytotoxin (108, 163, 164). Although the strain produced a lower cytotoxic
activity, similar morphological changes were observed in HEp-2 cells and a protein of
similar size was observed following SDS-PAGE. A protein o f comparable molecular
weight was also present in crude concentrated filtrates from other cytotoxic strains of

Campylobacter sp., indicating that the release o f the porin-LPS complex is not unique to
C.jejuni strain 2483. Carbohydrates were also present in the cytotoxic product isolated
from C. jejuni strain 3969. Although this strain was untypeable with available Lior
antisera, it proved to be a biotype 1, Penner serotype 0:50. The differential in cytotoxic
activity between strain 3969 (low toxin activity) and 2483 (high toxin activity) could be a
growth-rate dependent phenomenon since the release of the porin-LPS complex may
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occur most avidly doling cell death or may be lost during active replication o f the
organism. Strains with a higher growth rate could therefore produce quantitatively more
complex (156). Recently a vacuolating cytotoxin similar to that produced by H. pylori
was detected in the stools o f children with diarrhea, even though no etiologic diarrheal
agent was identified (80). Although many organisms have been shown to induce vacuole
formation, this process may be porin-mediated following release from dead or dying
organisms (156).
Lectin studies showed that the carbohydrate portion o f the LPS which co-purified
with the porin possessed terminally-linked mannose and sialic acid terminally linked a(2-3)
to galactose as well as galactose-P( l-4)-N-acetylglucosaniine complexed together with
hybrid N-glycan structures. Based on the thermostable somatic (0 ) antigen, the strain of

C. jeju ni used in this study was type 0 : 11. The chemical composition o f the LPS of this
serotype is currently under investigation in collaboration with Dr. Malcolm B. Perry of the
National Research Council in Ottawa. The positive result with the lectin MAA suggests
that the strain may be related to serotypes 0:2 or 0 :4 (10, 11). The LPS from the 0:2
and 0 :4 serotypes o f C. jejuni have core structures that mimic those present on Gmi and
Gougangliosides and have been linked to post infectious neuropathies (8). The presence
o f terminally-linked mannose may be unique to the LPS from selected serotypes o f C.

jejuni. Treatment o f the isolated complex with sodium meta-periodate, neuraminidase and
N-glycosidase F had no effect on the toxicity elicited by the complex, suggesting that the
LPS is not an integral component o f the cytotoxic activity but that it may play a protective
role. Indeed, it is possible that it may have interfered with the enzymatic degradation by
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trypsin and may offer an explanation for the disparity in trypsin inactivation data o f
previous reports. To address this disparity, the complex could first be treated with the
glycosidases followed by trypsin to see if this permits degradation by first removing the
carbohydrate moieties and exposing the protein component. Under native conditions, the
LPS likely forms complexes with the porin and protects it from discrete staining with
Coomassie blue. The cytotoxic protein is only revealed by Coomassie blue or silver
staining after boiling in sample buffer containing SDS and P-mercaptoethanol prior to
SDS-PAGE. Since the porin from C. jejuni has been classified as part o f the trimeric
porin family, it was not unexpected that it must be heat denatured in order to resolve the
protein component o f the cytotoxic complex (176).
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SECTION m

Localization and DNA sequencing of porin gene from
Campylobacter jejuni

3.1 Abstract
Campylobacter jejuni is a frequent enteric pathogen which causes diarrheal disease
in developing and underdeveloped countries. Several pathogenic mechanisms have been
postulated for the organism resulting in disease and these include adherence of the
organism to gut cells followed by intracellular replication. In addition, several exotoxins
have been attributed to the pathogen, hi this study, a porin-lipopolysaccharide complex
was identified from C. jejuni strain 2483. Degenerative primers from the sequenced
cytotoxic porin protein were synthesized and using a combination o f vectorette
polymerase chain reaction (PCR), cloning and inverse PCR, a 1.45 kilobase (kb) fragment
o f DNA was sequenced and found to have a single open reading frame containing the
corresponding N-terminus o f the sequenced cytotoxic porin protein. The porin gene,
designated porA, consisted o f a 1275 bp open reading frame encoding a 45.6 kDa protein
with a calculated p i o f 4.35. The protein possessed a 22 amino acid leader sequence. The
translated protein had a 50% sequence similarity with Haemophilus influenzae major
outer membrane protein P2 but showed only 23% sequence identity. A total o f 32 strains
o f Campylobacter sp. and related organisms were screened by PCR for porA and tested
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for expression o f a cytotoxin in cell culture using HEp-2 cells following growth o f the
organisms in a biphasic system. Twenty-one o f the 32 strains (66%) were genotypically
positive for the cytotoxic protein gene and o f these 21 o f 23 (91%) were C.jejuni strains
suggesting that the porin gene was highly conserved. All 32 o f the strains examined
(100%) were phenotypically positive for a cytotoxin when their filtrate were assayed for
toxicity in tissue culture using HEp-2 cells.

3.2 Introduction
Campylobacterjejuni is recognized as a cause o f bacterial-induced diarrhea in
both developing and underdeveloped countries (230). Active surveys conducted in the
United States have estimated the number of cases o f campylobacteriosis to be 2.5 million
per year making it a multi-million dollar disease (230). Symptoms caused by C. jejuni can
range from watery to bloody diarrhea (172, 230). In most cases campylobacteriosis is a
self-limiting disease but in the more severe cases, antibiotic intervention with macrolids or
fluoroquinolones or rehydration therapy is necessary to eradicate the infection (172).
The organism has been reported to possess several virulence factors that may be
responsible for disease (65, 166, 239) but little is known regarding the genetic processes
that surround their production One virulence factor, a toxin has been cloned and
sequenced successfully and this is the cytolethal distending toxin (CLDT) of C. jejuni
(202). The CLDT operon was found to contain three open reading frames (ORF)
designated cdtA, cdtB and cdtC and these correspond with 30.1-, 28.9- and 21.1-kDa
proteins respectively (202). Escherichia coli minicell experiments have shown that all
three genes are necessary for the production o f the active toxin. Screening of multiple
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strains o f Campylobacter sp. by polymerase chain reaction (PCR) for the presence o f the

cdtB gene and HeLa cell assays for the expression o f CLDT revealed that all the strains
tested carried the gene and tested positive in the cell culture assay (202). Johnson and
Iio r (109) originally reported that 41% o f 718 isolates of Campylobacter sp. screened for
the production o f CLDT were positive; however, isolates screened for the cdtB gene
suggested that this percentage may be higher than was previously reported (109, 202).
Genetic studies involving the production o f an enterotoxin by C. jejuni revealed DNA
similarities between a postulated GMi binding site on the toxB gene from Vibrio cholerae
and the E. coli heat-labile enterotoxin (eltB) gene. Despite this an enterotoxin gene has
not been successfully cloned and sequenced from C. jejuni (36).
C. jejuni has a genome estimated to be 1.7 Mb in size as determined by pulsed
field gel electrophoresis (PFGE) (246) while the % mol guanidine+cytosine ranged
between 29-36 mol % ( 244, 246) The organism has the capability to transform free DNA
as well as to be transduced by bacteriophages and to transfer DNA between strains by
conjugation (207,248). These genetic exchange mechanisms could naturally facilitate the
spread o f antibiotic resistant determinants between strains (248) and may allow for the
acquisition o f toxin genes (182). A number of genes have been sequenced from C. jejuni
(Table 1.3) (244); however, the majority o f these take the form o f highly conserved or
“housekeeping” genes such as serine hydroxylmethyltransferase iglyA) (42) and yglutamyl phosphate reductase gene (proA) (149). In addition, genes such as JlaA and JlaB
encoding fiagella proteins (86) and peb4A , an antigenic surface protein (31) have been
cloned and sequenced. Difficulties such as gene instability and failure to express
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functional products have been encountered and this has made genetic analysis o f C. jejuni
problematic (202,244).
Several porin genes from various bacterial species have been purified, cloned and
sequenced (39, 81,90, 91, 169). Porins usually exist as a single, monomeric protein (90,
176) or as homotrimers (26, 39) and possess a range o f pore sizes (26, 91). Porins are
functional components o f the outer membrane o f bacteria which allow for exchange of
solutes as well as permit the excretion o f waste products. One characterized porin from

E. coli has been found to occur at a frequency o f 10s on each bacterial cell (169, 267)
making it the most abundant molecule present on the cell surface (209, 267). Porins have
also been found to induce morphologic changes in HEp-2 cells as a result o f alterations in
the cytoskeleton following incubation with increasing concentration of the purified protein
(54). Characterization o f the protein with respect to its pore capabilities has already been
reported (103). The genetic sequence and comparative analysis of the porin gene, porA ,
from C. jejuni is reported here together with data from the examination o f 32 strains of

Campylobacter sp. and related organisms for the presence of this gene. This is the first
study to provide information regarding the genetic sequence and the composition o f the
translated porin protein.

3.3 Materials and Methods
3.3.1 Bacterial Strains and Media.
C. jejuni, strain 2483, was isolated from a patient with gastroenteritis (150, 151)
and was used for the localization and sequencing o f the porin gene. The organism was
passed twice on tryptic soy agar containing 5% sheep blood (TSA) following isolation
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from the patient and was subsequently stored at -70 ° C in tryptic soy broth containing 5%
sheep blood. Strains o f Campylobacter sp. and related organisms were maintained at 80°C in giycerol-p eptone w ater as part o f the reference collection at the Laboratory
Centre for Disease Control, Ottawa Canada.

3.3.2 Generation of Vectorette libraries.
Genomic DNA from C. jejuni strain 2483 was purified as described previously
(152). A total o f 15 pg o f genomic DNA was digested for 2 h at 37°C with 120 U o f

BairiHL, EcdRI, Nhe I, Spe I, H ind m , Bgl IT and Bel I restriction enzymes (Boehringer
Mannheim, Laval, Quebec, Canada). The vectorette oligonucleotides, vectorette universal
primer and degenerate primers were synthesized on an Oligo 1000M DNA synthesizer
(Beckman, Fullerton, Ca.) and are listed in Table 3.1. Common linkers were allowed to
anneal as outlined previously (213) by adding 10 mM concentration o f each
dephosphorylated 57-mer top strand with the 53-mer bottom strand (3’-VP) at 65°C for 2
min followed by cooling to 37°C over the next 20 min. A 30 pi ligation mixture was made
with each digest containing 2.5 pg o f digested genomic DNA, 1 pi o f annealed common
linkers (with the corresponding compatible ends; Le. BamHI digested genomic DNA with
5’-BamHI-), 1 mM adenosine triphosphate (ATP), 10 U T4 DNA ligase (Boehringer
Mannheim) and 10 mM dithiothreitol (DTT). Each reaction was incubated overnight at
15°C (Fig 3.1).
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A igpgtprf genomic DNA

annealed common linker
ligate common linkers to genomic DNA and PCR
amplify with universal vectorette primer and
oligonucleotide (p-3F) generated from N-terminal of
porin protein

universal vectorette primer
electrophorese amplicon on agarose gel

v

1500 bp

->■ excise band and DNA
sequence

600 bp

Figure 3.1. Schematic diagram o f vectorette PCR.
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3.3.4 Polymerase chain reaction of vectorette library and inverse PCR.
Primers p-lF, p-2F and p-3F were generated from the sequenced amino-residues
(26, section 2.4.2) number 23 to 29, 21 to 27 and 4 to 10 respectively. Design o f the
primers was aided by a codon usage chart available through Genebank. Three separate
PCR reaction mixtures were prepared by adding 1 pM of each degenerative primer (Table
3.1) with 1 pM universal vectorette primer (UVP), 100 pi 10X PCR buffer (500 mM KCL,
100 mM Tris-HCl (pH 8.3), 1% Triton X-100, 30 mM MgCk), 200 pi o f a stock solution
containing 200 mM o f each deoxynucleotide triphosphates (dNTP), and 20 U Taq DNA
polymerase (Promega, Madison, WI). The final volume was raised to 1 ml with sterile
double distilled water (ddHjO). Five microliters o f each ligation mixture were added to
50 pi o f each o f the PCR reaction mixtures followed by amplification in a PE9600
thermocycler (Perkin-Elmer, Foster City, Ca.) with initial melting temperature set at 95°C
for 2 min followed by 35 cycles at 95°C for 30s, 55°C for 30s and 72°C for 2 min with a
final extension at 72°C for 2 min. The PCR reactions and a 100 bp ladder (Gibco BRL,
Grand Island, NY) were electrophoresed on 1% low melting point agarose (LMP) (Gibco
BRL) in IX Tris acetate, EDTA buffer at pH 8.4 and stained with 0.5 pg/ml ethidium
bromide (Sigma) for 30 min. PCR products were excised from the agarose and extracted
using the Promega PCR Preps DNA purification system (Promega).
Inverse PCR was performed by first adding 2.5 pg o f Hind HI digested genomic
DNA with 6 pl o f 100 mM DTT, 6 pl o f 10 mM ATP, 5 U o f ligase (Boehringer
Mannheim), 6 pl o f ligase buffer (Boehringer Mannheim) and sterile dcffkO to give a final
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volume o f 60 pl (Fig 3.2). The mixture was allowed to ligate overnight at 15°C.
Following Hgation, PCR was performed as stated above using p-3F and p-7R primers
(Table 3.1) for 35 cycles. The PCR reaction was run on a 1% low melting point (LMP)
gel and stained with ethidhim bromide. Amplicons were extracted with Promega PCR
Preps DNA purification system (Promega) and DNA sequenced. The amplicons were
DNA sequenced on an A B I377 automated DNA sequencer (Applied Biosystems, Foster
City, Ca) using the Prism dye terminator cycle sequencing kit (Applied Biosystems).
DNA sequence analysis was performed using Sequencher 3.0 (Gene Codes Corporation,
Ann Arbor, MI) and PC/Gene (Intelligenetics, Mountain View, Ca.).

3.3.4 Southern blot analysis of genomic DNA.
A total o f 5 pg o f C. jejuni strain 2483 genomic DNA was digested overnight at
37°C with 20 U o f each restriction enzymes (section 3.3.2). Prior to electrophoresis,

Hind ID digested lambda DNA was labeled with digoxigenin-1 l-uridine-5’-triphosphate
using a random labeling kit (Boehringer Mannheim) for 1 h at 37°C. Digested DNA was
electrophoresed on a 1 % agarose gel (Gibco) in IX TAE buffer together with the Hind
m digested lambda DNA ladder (Boehringer Mannheim). Following gel electrophoresis,
the gel was Southern blotted using established procedures (222) by first placing the gel in
denaturing solution (0.5 M NaOH, 1.5 M NaCl) for 1 h at room temperature on an orbital
shaker followed by 1 h in neutralizing solution (0.5 Tris-HCl, pH 7.5, 1.5 M NaCl) under
the same conditions. The genomic DNA was transferred to Hybond-N+ nylon membranes
(Amersham, Arlington, Heights, 1L.) using a Posiblot system at 75 mm Hg for 90 min

79

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

HindTK digested genomic DNA

1

circularize fragments with T4 DNA
ligase overnight

PCR amplify with p-3F and p-7R
► p-3F
> p -7 R

I

electrophorese PCR amplicon

1500 bp
extract 800 bp amplicon
and DNA sequence

600 bp

Figure 3.2. Schematic diagram o f the inverse PCR procedure.
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(Stratagene, Aurora, Ontario, Canada). After transferring, the membrane was washed
once with 2X sodium chloride solution containing sodium citrate (SSC) before being UV
cross-linked in a UV Stratalinker 2400 (Stratagene). Cross-linked membranes were
placed in 10 mlprehybidization solution (Gibco BRL) for 1 h at 55°C. The PCR amplicon
generated from the p-3F and p-6R primers (Table 3.1) was extracted from a 1% low
melting point agar (LMP) and 10-25 ng was digoxigenin-labeled using a PCR digoxigeninlabeling kit (Boehringer Mannheim). The PCR method was similar to that used for the
vectorette PCR except that 15 cycles were used instead o f 35. Approximately 50 ng of
the lambda ladder probe and the digoxigenin-labeled cytotoxic protein probe were heat
denatured at 100°C for 10 min, placed on ice for 5 min and then added to the
hybridization solution at 55°C overnight.
Following hybridization, the membrane was washed twice for 15 min each in 2X
SSC in 0.1% SDS at room temperature followed by two 15 min washes first at 55°C in
IX SSC in 0.1% SDS and then 0. IX SSC in 0.1% SDS at room temperature. The
washed membrane was blocked in 5% blocking reagent (Boehringer Mannheim) for 1 h on
an orbital shaker prior to the addition o f anti-digoxigenin antibody conjugated to alkaline
phosphatase (Boehringer Mannheim) used at a dilution of 1:5000 for 1 h. The membrane
was washed 3 times for 5 min each in low salt Tris-bufFered saline (TBS) and placed in a
1:20 dilution of CPD-Star lumigen substrate (Tropix, Bedford, Ma) in washing buffer
containing 0.1M Tris-HCl at pH. 9.5, 0.1 M NaCl and 50 mM MgCk for 5 min. The
membrane was exposed to high performance autoradiography film (Hyperfilm-MP)
(Amersham) until a suitable band intensity was achieved.

si

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

3.3.5 Cloning and DNA sequencing of porin gene.
The region o f the genomic DNA digested with Spe I which reacted with the
cytotoxic probe, was excised from a subsequent LMP gel, and extracted using Geneclean
(Biol 101, LajoHa, Ca). To determine the optimal concentration o f insert to vector,
various concentrations o f inserts were ligated to SO ng o f Xba I digested and alkaline
phosphatase (Promega) treated pUC 19 (Pharmacia Biotech, Uppsala, Sweden) with 2.S
U o f T4 DNA ligase and 1 mM ATP (Promega) at 15°C overnight. A total of 50 ng of
vector was used to transform Epicurian coli XLl-bhie competent cells as outlined by the
manufacturer (Stratagene) and 100 pl was plated on Luria broth (LB) agar plates
containing 200 pg/ml ampicillin. For color development, plates were covered with 50 pl
halogenated indolyl-3-D-galactoside (Bhio-gal) at 20 mg/ml (Gibco BRL) and 15 pl
isopropylthio-P-galactoside (IPTG) used at 0.5 M (Gibco BRL). These were allowed to
dry prior to the addition o f transformants.
Transformants were picked from the plates and grown overnight in 3 ml of LB
with 200 pg/ml ampicillin. Plasmid preps were performed on 1.5 ml o f culture using the
Promega miniprep DNA purification system (Promega). A total o f 50 ng o f purified
plasmid from the Spe I ligation was added to 50 pl PCR mixture containing p-3F and p-6R
and amplified for 20 cycles using the same methodology outlined above (section 3.3.3).
Reactions were electrophoresed on a 1% agarose gel in TAE buffer and stained with
ethidiuin bromide. Plasmids from positive clones were sequenced as described above
(section 3.3.3) using the primers described in Table 3.1. PCR was performed on genomic
DNA using primers p-15F and p-16R using the same method as for the porin probe.
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3.3.6 Screening of C jeju n i isolates for porin gene and cytotoxin production.
A total o f 32 strains o f C. jejuni and related organisms, including strain 2483
(Table 3.2), were grown on tiyptic-soy agar containing 10% sheep blood for 48 h in a
microaerobic environment. A loopfiill o f each strain were removed from the plate and the
DNA extracted as previously described (25). PCR conditions were as stated above except
50 ng o f genomic DNA was used in the reaction with p-3F and p-6R for 35 cycles at an
annealing temperature o f 55°C. The PCR reactions were then mixed with 6X sample
buffer and 20 pl o f each were electrophoresed on a 1% agarose gel in TAE buffer and
stained with ethidium bromide. Each strain was also screened for phenotypic expression
of a cytotoxin in a biphasic system using 12-well plates (Costar). A loopfiill of each strain
was inoculated into 2 ml o f minimal essential media (MEM) without fetal bovine serum
(FBS) and used to overlay 1 ml of Meuller-Hinton agar present in the bottom o f the wells.
The organisms were grown for 48 h at which time the liquid medium was removed and
centrifuged to remove the bacteria. HEp-2 cells were subcultured into 96 well plates at a
density of 1 X 104 cells/well with 200 pl MEM supplemented with 10 % FBS 24 h prior to
the addition o f the toxic filtrate. The supernatant fluid was assayed for cytotoxic activity
by replacing the 200 pl o f growth medium used in subculturing the Hep-2 cells with 200
pl of the organism free filtrate. The cells were monitored over a 48 h period for
cytological changes. E. coli 0157:H7 strain 3787 (H19), positive for verotoxin type 1
(VT1), and strain 90-2380, positive for verotoxin type 2 (VT2), were used as positive
controls for the cell culture assay while uninoculated medium was used as the negative
control.
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Table 3.2.
Screening o f 23 strains o f C. jeju ni and 9 strains of related organisms for
phenotypic expression o f a cytotoxin and presence of porA using primers specific for the
porin gene sequenced from C. jejuni strain 2483.

Organism

LCDC
number

Source

Lior
serotype

Biotype

Toxin
positive

PCR
positive

C. jeju n i

3454
3969
4951
4966
6847
7099
7288
8916
9214
9541
9543
9555
10403
10673
14040
14906
15151
16323
16334
16336
16388 (2483)
1
2074
729
348
5754
7055
8494
9365
13220
3787(19)

human
NA
human
human
human
chicken
water
human

4
untypabie
7
7
1
61
9
94
2
82
82
23
36
82
82
82
82
82
82
82
82

la
I
I
I
la

+
+

+

C. lari
C. coli
C. sputorum subsp. fecalis
C. fe tu s subsp. fe tu s
C. hyointestinalis
C. jeju n i subsp. doylei
A . butzleri
E. coli VT1+
E. coli VT2+

H19

human
water
water

human
human
human
human
human
human
beef
human
human
human
NA
NA
NA
NA
NA
NA
human
NA
human
NA
human

NT
NT
NT
NT

II
Ila
la
II
II
I
la
II
II
I
I
I
II
II
II
I
II
I
I
NT
NT
NT
NT

7

iiia

NT
NT

NT
NT

4
36
31

14

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

NT not tested
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3.3.6 Genbank accession number. Genbank U96452

3.4 Results
3.4.1 Vectorette PCR.
Vectorette PCR was performed using the genomic DNA digested with N he I
ligated to its corresponding common oligonucleotide which generated amplicons suitable
for DNA sequencing. The universal primer (UVP) and p-lF, p-2F and p-3F yielded
amplicons of similar size of approximately 800 bp in length which was consistent with the
position of the N he I restriction site (Fig 3.3) and the position of the primers (Table 3.1).
DNA sequencing of the three amplicons revealed the same sequence which, when
translated, contained an ORF corresponding to' the protein sequence obtained from the Nterminus of the cytotoxin (26). No other amplicons were seen with the remaining genomic
digests when the PCR conditions were maintained. From the DNA sequence, primer p-6R
was designed from nucleic acid positions 768 to 749 of the sequenced amplicon. This new
primer was used in a PCR reaction with primer p-3F to amplify a 650 bp amplicon. The
amplicon was used as a DNA probe on a Southern blot to localize the cytotoxic porin
gene.

3.4.2 P artial cloning and sequencing of cytotoxic porin protein.
Southern blot analysis of the digested genomic DNA using the digoxigenin-labeled
cytotoxic porin probe yielded several discrete bands when probed with the 650 BP probe
(Fig 3.4). The Spe I fragment was chosen, purified and ligated to pUC 19 and used to
transform Epicurian coli XL 1-blue competent cells. One colony from the Spe I digested
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Figure 3.3.
Schematic diagram o f the sequencing reactions and restriction map of porA from

C. jejuni strain 2483 showing the restriction sites for the enzymes used in the generation
o f the vectorette library. The arrows designate the direction and primer used in the
sequencing o f the intact gene.
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Figure 3.4.
Southern blot analysis o f genomic digests using a digoxigenin-labeled 650 bp
probe. Lanes 1 and 10: Hind IQ digested lambda DNA; Lane 2: Hind HI digested C.

jejuni genomic DNA; Lane 3: Bam HI digested C. jejuni genomic DNA; Lane 4: Bgl I
digested C. jejuni genomic DNA; Lane 5: Nhe I digested C. jejuni genomic DNA; Lane
6: EcoRl digested C. jejuni genomic DNA; 7: Bel I digested C. jejuni genomic DNA;
Lane 8: Spe I digested C. jejuni genomic DNA; Lane 9: E. coli Xba I digested genomic
DNA
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and extracted genomic DNA, which was positive by PCR for the 650 bp product was
designated Cj08 and this was sequenced. Inverse PCR was only performed on Hind III
digested DNA because o f the results obtained from the Southern blot analysis using the
650 bp probe and the restriction map (Fig 3.4) o f the amplicon initially generated from the

Nhe I vectorette library. The Southern blot showed a weak reaction between the
digoxigenin-labeled probe and an approximate 800 bp fragment making it a potential
candidate for amplification by inverse PCR. A new primer, p-7R, which was generated
from positions 5’-209-> 190-3’ o f the sequenced amplicon from the vectorette PCR,
together with p-3F produced an 800 bp product with the ligated Hind IQ digested
genomic DNA. When sequenced the amplicon was found to contain the N-terminus o f the
porin protein along with the entire leader sequence with the start codon and the ribosome
binding site. The sequence data and translated protein obtained from the clone and the
inverse PCR are shown in Fig 3.5. The restriction map revealed a Spe I restriction site at
position 6 o f the functional gene therefore the Spe I clone only contained part o f the
functional gene but the remainder o f the gene was elucidated from the sequence the
amplicon generated from the inverse PCR reaction.
The entire gene was found to be 1275 bp in length and was designated porA. The
protein encoded was 424 amino acids in length (Fig 3.5) and had a calculated molecular
weight o f 45.6 kDa and a p i o f 4.44. The leader sequence was found to be 22 amino acid
residues in length and was cleaved from the active protein conforming to the -3,-1 rule
(12) between the Ala->22 (A) and Thr—>23 (T), which was the first amino acid residue in
the sequenced protein (26, section 2.4.2). The mature protein, minus the leader sequence
has a calculated molecular weight o f 43.5 kDa and had a pi o f 4.35. These findings were
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Figure 3.5.
The nucleotide sequence of porA from C. jejuni strain 2483. Single underlined sequence represents the
putative Shine-Dalgamo ribosome binding site (RBS), -10 and -35 sequences and double lines represents a stem
loop structure which may indicate a rho-independent transcription termination site with a 5 bp loop followed by a
poly-T region o f DNA. Bold face letters represent initiation codon and
numbering is for the nucleotide and amino acid count.

represents termination codon and the

consistent with previous reports (26, 103, 118) regarding the size and pi o f the porin
protein from C. jejuni. Primers, p-15F and p-16R were subsequently designed to PCR
amplify the entire porin gene (Fig. 3.6) as well as for use in the sequencing reactions.

3 .4 3 Sequence analysis.
Sequence homology searches were performed on the entire ORF and translated
protein using GCG (Genetics Computer Group, Madison, Wl). The translated porin
protein from C. jejuni strain 2483 had no significant homology with any characterized
protein except with the previously described C. jejuni porin protein (26) and the 45 kDa
and 51 kDa outer membrane proteins form Wolinella recta (117). However, the DNA
sequence had the greatest similarity with H. influenzae outer membrane protein P2 over
short stretches following a BLAST search (BLAST; Beckman Center for Molecular and
Genetic Medicine, Stanford University o f Medicine) (Fig. 3.7). A comparative analysis o f
the translated porin from C. jejuni strain 2483 and several bacterial outer membrane
proteins is shown in Fig 3.8. C. jejuni porin protein had a 50% sequence similarity but
only 23% sequence identity with the H. influenzae major outer membrane protein P2. In
addition, in those regions o f the DNA where the homology was greatest, the protein
sequence identity was as much as 72%. The porin from C. jejuni also had a 46%
similarity

and 21% identity with the Enterobacter cloacae pore forming outer membrane

protein PhoE, 44% similarity and 21% identity with Klebsiella pneumoniae PhoE, 43%
similarity and 17% identity with Salmonella typhi OmpC, and 42% similarity and 19%
identity with E. coli PhoE. When the porin from C. jejuni was compared to the consensus
sequence obtained from an alignment o f OmpF, OmpC, PhoE and Lc o f E. coli, PhoE
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Figure 3.6.
PCR product generated from p- 15F and p- 16R which were used to amplify the
entire porin gene. Lanes 1 and 3: 100 bp ladder (Gibco); lane 2: PCR amplified product..
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Figure 3.7.
DNA sequence homology between H. influenzae outer membrane protein P2 and porA from C. jejuni strain 2483.
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Figure 3.8.
Alignment o f C. jejuni PorA with H. influenza P2, E. cloacae PhoE, K. pneumoniae PhoE, S.

typhi OmpC, and E. coli PhoE using GCG (Genetics Computer group). Capital letter represent identical
or conserved changes, small letters represent mismatches in the sequences and spaces (...) were inserted
in order to achieve the best alignment.

represents termination codon.

of K. pneumoniae and ompC of S. typhi (176) a 45% similarity and 20% identity was
found (Fig. 3.9).

3.4.4 Screening Campylobacter sp. for porA an d cytotoxin production.
Results o f screening C. jejuni for phenotypic and genotypic expression of the
cytotoxin gene are summarized in Table 3.2 (pg 85). It was found that all 32 strains of

Campylobacter sp. and related organisms produced a cytotoxic component when the
filtrate from the biphasic growth system was assayed in tissue culture but only 21 of 32
(66%) were PCR positive using the primers (p-3F and p-6R) specific for porA. However,
21 o f 23 (91%) o f the C. jejuni strains screened for porA were PCR positive for the 650
bp product showing that the porin gene was highly conserved among strains of C. jejuni,
especially Lior serotype 82, but was not conserved between related species of

Campylobacter. The two strains o f C. jejuni which were PCR negative for the porA gene
belonged to Lior serotype 36. More work is needed to determine if the negative PCR
result is conserved among strains within this group.

3.4 Discussion
The major outer membrane protein (MOMP) o f C. jejuni was first isolated and
reconstituted into lipid bilayer membranes and found to form small channels consistent
with that o f a porin (103). The MOMP has an apparent molecular weight o f 45 kDa
under native conditions and since 3-folded monomers are needed to form the functional
porin, it was confirmed to be part o f the trimeric porin family (26). The N-terminal
sequence has been elucidated and been found to contain little homology with other
bacterial porin proteins (26) but it did share homology with two outer membrane proteins
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Figure 3.9.
Comparative analysis o f the enterobacterial consensus sequence with the C. jejuni translated PorA.
Vertical line

represent identical residues, colons represent changes with a comparison value ^ 0.5;

represent

residues with a comparison value £ 0.1. Gaps were inserted in order to obtain the best fit. Underlining in the
o
o

enterobacterial consensus sequence represent hypothetical membrane spanning regions as determined by the method of
Chou-Fasman (176), while double lines represent stretches o f extended conformation in PorA as determined by the
method o f Gamier (78).

represents termination codon.

from W. recta (117). In this thesis it was reported that the porin-LPS complex from C.

jejuni possessed a heat-labile cytotoxic activity (section 2.4.1)
This is the first study to provide information regarding the complete genetic
sequence and the translated porin protein from C. jejuni. The 1275 bp ORF had a % mol
guanosine+cytosine content o f 36.8 mol % (Fig. 3.5) which is slightly higher than the
range previously described for C. jejuni chromosomal DNA (244, 246). A putative ShineDalgamo (SD) sequence which has previously been described (199) with a sequence o f 5’AGGAG-3’, lies centered 10 bp upstream from the initiation codon ATG. A putative -35
region, which has been previously described (199) is centered 87 bp upstream from the
initiation codon with a sequence o f 5’-TTTACT-3’ while a putative -10 region, 5’TTAAGA-3’ is centered 57 bp upstream (Fig 3.5). Both the -35 and -10 sequences were
predicted as putative sites using PC/Gene software package (Intelligenetics, Inc.) and
comparative analysis with putative sites from published sequences from C. jejuni. A
potential termination sequence was present 25 bp down stream from the stop codon 5’TAA-3’ (Fig 3.10). It consisted o f a 9 bp dyad stem loop with a predicted stability of 19.2 kcal/mol separated by 5 impaired bases which could comprise the loop structure.
This is followed by a poly-T region and could signify a rho-independent termination
sequence (4).
With very few exceptions, codon usage in the coding region of porA gene were
consistent with the compilation available through Genbank (Table 3.3). For instance, Tyr
was equally encoded by UAU and UAC while GUA was used more frequently to encode
Val rather than GUU and AUC encoded lie instead of AUU. The most striking difference
was the number o f Phe encoded by UUC which had previously been shown to be encoded
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1410 - G:C - 1420
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G: C
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/
GTCTAACTTC

\
TTTTTATGCC

Figure 3.10.
Stem loop structure o f the termination sequence. Numbering represents the
position of the loop in the 1450 bp fragment containing the ORF o f the porA gene from
Fig 3.5.
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Table 3.3.
Codon usage chart for the 1275 bp open reading frame porA from C. jejuni
strain 2483.

Ala

Cys
Asp
Ghi
Phe
Gly

His
Tip
Tyr

UAA
UAG
UGA
GCU
GCC
GCG
GCA
UGU
UGC
GAU
GAC
GAG
GAA
UUU
GGC
GGA
GGG
GGU
CAC
CAU
UGG
UAC
UAU

-

He

-

35
1
1
11
0
0
30
2
2
15
10
3
9
0
32
2
2
5
11
12

Lys
Leu

Met
Asn
Pro

Gin

AUC
AUA
AUU
AAA
AAG
CUU
CUA
CUG
UUG
UUA
cue
AUG
AAC
AAU
CCC
ecu
CCA
CCG
CAG
CAA

9
2
4
22
0
17
4
0
0
17
0
2
19
15
0
1
3
0
2
13

Arg

Ser

Thr

Val

CGU
AGA
CGC
CGA
AGG
CGG
UCA
UCC
UCG
UCU
AGC
AGU
ACG
ACC
ACU
ACA
GUC
GUG
GUU
GUA

1
7
1
0
0
0
6
0
0
6
7
6
1
0
14
14
1
2
12
20
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more frequently by UUU while AAC rather than AAU encoded Asn. These frequencies
were most likely due to the quantity o f % mol G+C residues in the coding region and
these may confer an increase in gene stability at increased temperatures especially as the
organism is considered to be thermophilic.
The ORF was found to produce a 45.6 kDa protein with a p i o f 4.44, both of
which are consistent with previous reports on the C. jejuni porin protein (26, 103, 118).
The translated protein was also found to contain several hydrophobic regions as
determined by the method ofNovotny and Auflray (179) (PC/Gene) (Fig. 3.11).
Structural prediction using the method of Gamier (78) (Fig. 3.9) (PC/Gene) and Novotny
(179) (Fig 3.11) indicated there was also considerable secondary structure associated with
the porin with 50% o f the amino acids forming extended or P-pleated sheet
conformations. This was consistent with previous circular dichroism (CD) findings (26) as
well as with other bacterial porin proteins from Rhodobacter capsulatus, E.coli and E.

cloacae (176). The number of residues necessary to span the membrane has been
estimated from 7?. capsulatus porin to be between 6 to 17 residues in length (205). Based
on this assumption, together with the P-pleated sheet diagram and hydrophobic chart (Fig
3.11), there may be as many as 12-membrane spanning domains while R. capsulatus
contains 8 P-strands (176). The number o f membrane spanning regions was predicted by
the method o f Novotony using PC/Gene software package. The program determines the
propensity o f a given residue to exist in a certain structure by examining the charge profile
o f each amino a d d in the primary structure.
The relative amount of sequence identity was low compared to the sequence
similarity. This indicated that, although the primary structure was quite distinct, the
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A. PorA from C. jejuni strain 2483
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Figure 3.11.
Hydrophobic profiles and beta sheet propensities as determined by the method o f
Novotny (179) using PC/Gene software package. A) C. jejuni strain 2483 PorA; B) H.

influenzae P2; C) C. jejuni FlaA (87).
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properties associated with the 424 amino acid protein were similar to those of other wellcharacterized porins (Fig 3.8). For instance, the relative amounts o f basic, polar and
acidic residues are similar to that oiH . influenzae P2 as well as the enterobacterial
consensus sequence; however, there was a greater frequency of hydrophobic residues in
the porin from C. jejuni (Table 3.4). This could coincide with more membrane spanning
regions leading to a more extensive secondary structure. When the C. jejuni porin
sequence was compared to the hypothetical folding pattern o f the enterobacterial
consensus sequence (Fig 3.11), there was no more significant similarities in the membrane
spanning regions o f the consensus sequence than in the rem aining sections. Comparison
o f the N-terminal sequences o f H. pylori porin proteins (56, 64) showed very little
sequence identity with the porin from C. jejuni (Fig. 3.12) However, when the sequences
were compared for similarities, the porin from C. jejuni had the greatest similarity with
HopC (57%) followed by HopE (55%) then HopD and HopB (50%) and the least
similarity with HopA (47%) (Fig. 3.12). TTie conductance levels of the channels formed
by the H. pylori porin range from 0.25 to 0.36 nS (64) which is considerably lower than
the conductance o f 8.82 nS reported for the C. jejuni porin (103). The molecular weights
o f each o f the H. pylori porins are greater than the porin from C. jejuni and also appear to
present as monomers in lipid bilayers (64) instead o f the trimeric form similar to C. jejuni
porin (26).
The MOMP has been found to elicit an immune response both in humans (178)
and rabbits (65) making it a suitable candidate for vaccine development. PCR studies to
determine the frequency o f the porin gene in other strains o f C. jejuni showed that 95% o f
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Table 3.4.
Comparison o f the amino acid composition o f PorA from C. jejuni strain 2483, H.

influenzae P2 and the consensus sequence from enterobacterial porin. Numbers in
parentheses represent residues in the leader sequence.
No. o f residues/mol in:
Amino Acid

............

C. jejuni
PorA

H. influenzae P2*

Consensus
Enterobacterial porinb

2 2 (2)

3 0 (2 )
16
7

23

9
4

32
17

17
24

34
17

34(1)

2 5 (1 )

24

0

0

0

15
44(1)
25(2)
29
23

14
4 0 (1 )
17(1)
2 4 (1 )
23

17
40
18

48(8)
15
38(4)
2 ( 1)
23 (1)
4
5
35 (2)

2 4 (8 )
15(1)
2 4 (2 )

26
9
23
5
21
4
3
15

Basic
Lys
Arg
His

11

1

Acidic
Asp
Glu
Polar
Asn
Cys
Gin
Gly
Ser
Thr
Tyr

22
23

Hydrophobic
Ala
lie
Leu
Met
Phe
Pro
Trp
Val

1 ( 1)
13(1)
3

0
2 4 (1 )

adata derived from Hansen et al. (64)
bData dervied from H. Nikaido (176)
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Figure 3.12.
Significant sequence homology o f the C. jejuni, strain 2483, cytotoxic ProA and
the Helicobacter pylori porin family proteins using best fit (Genetics Computer Group
software package). Vertical lines represent identical residues; colons represent changes
with a comparison value £ 0.5;

represent residues with a comparison value ^0.1; “X”

represents unknown residue. Numbering designate the location o f the respective sequence
within the alignments
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these contained at least part, if not all o f the intact gene while the other Campylobacter sp.
and related organism were PCR negative. Previous reports indicated that only 60% of
pathogenic strains possessed a protein o f similar size as determined by SDS-PAGE and
Western blot analysis using antiserum against the MOMP from C. jejuni strain 85H (118).
The PCR results outlined above are intriguing, and may provide a new and efficient
method to differentiate C. jejuni from other Campylobacter sp. However, considerable
testing, including sequencing o f porin genes from related species o f Campylobacter is
required to identify regions o f the genes which are unique to a given species. The
potential for the development o f a recombinant vaccine using the porin protein is also
noteworthy. Previous studies by Gonzales et al. (90) have shown that T-cell activation
occurred through the induction oflymphokines by S. typhi porin which may lead to
protective immune response. Protection in guinea pigs was seen by using the
enterobacterial outer membrane protein PhoE as a vector to express B-cell epitopes on the
surface o iE . coli providing a vehicle for live vaccine development (250).
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Section IV
Preliminary effects of cytotoxic porin protein from
Campylobacter jejuni on host cell processes
4.1 A bstract
Campylobacterjejuni is recognized as one o f the major causes o f bacterialinduced gastroenteritis in developed and developing countries. C. jejuni possesses many
pathogenic mechanisms for inducing disease which include binding to and intracellular
replication within host cells as well as the production o f different toxic products. Among
those described are: 1) lipopolysaccharide (LPS) 2) hemolysin; 3) a much disputed
enterotoxin; 4) a cytolethal distending toxin (CLDT) and 5) a cytotoxin. Previous
sections outlined the purification and characterization of a 45 kDa cytotoxic protein and a
co-purifying carbohydrate moiety. Preliminary studies were conducted in order to define
the mode o f action o f the cytotoxin by evaluating the effects o f cytotoxic filtrate on cyclic
GMP levels and host cell protein synthesis. Levels o f cGMP were measured by
radioimmuno assay in INT-407 cells following intoxication with cytotoxic filtrate. Control
cells were found to contain 2.63 XIO'20 mol cGMP/cell while duplicate cells contained 2.7
XIO'20 mol cGMP/cell after being intoxicated for 24 h. The cytotoxin does not effect
cGMP levels in affected cells. The effects o f cytotoxic filtrate on protein synthesis in ENT407 cells were measured by assaying for incorporation of L-[3H]-leucine
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following intoxication. Intoxicated cells showed an 84% decrease in cellular protein
synthesis as compared to control cells. Purified cytotoxin was also found to induce DNA
fragmentation as early as 24 h post-intoxication in HEp-2 cells but not in Vero cells after
48 h o f intoxication. This could signify that the intoxicated cells are becoming apoptotic.
4.2 Introduction
Enteric pathogens colonize the intestinal tract and invade the tissue lining o f the
lumen by a number o f different m ech an ism s leading to intracellular replication (257).
Many produce potent exotoxin(s) leading to cell death and/or ion imbalance (138, 225,
257). C. jejuni has been shown to adhere to the epithelial cells lining the lumen of the
intestine via flagella, LPS and membrane proteins leading to the invasion o f the underlying
follicles (92, 119). In addition, C. jejuni has been shown to produce an enterotoxin similar
to that o f Vibrio cholerae (47, 53,108), as well as a cytolethal distending toxin (109, 202)
and a potent cytotoxin (85, 150, 151). However, the role that C. jejuni exotoxin’s play in
pathogenesis has not been elucidated.
Bacterial exotoxins can effect host cells processes a variety of different ways (94,
138). A family o f bacterial exotoxins, commonly referred to as bAREs (bacterial ADPribosylating exotoxins) modify proteins involved in crucial host cell functions leading to
cell death or ion imbalance (138). These particular exotoxins are commonly subunit
proteins consisting o f an A:B structure (138) and act by covalently transferring the ADPribose moiety o f NAD+ to specific eukaryotic target proteins leading to either activation
per se o r to inactivation o f the target protein (138). The enterotoxin produced by V.

cholerae (CT) and the heat-labile enterotoxin produced by E. coli (LT) are multimeric
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bAREs consisting o f 1 A-subunit surrounded by 5 B-subunits (225). The B-subunits are
involved in the binding o f the toxin to gangloside GMt present on the surface o f the
epithelial cells lining the lumen o f the intestine while the active A-subunit is translocated
into the cytoplasm o f the cell (138,225).
Both CT and LT act by ADP-ribosylating the GTP binding proteins present in the
intestinal epithelial cells leading to an increase o f intracellular cAMP. The increase of
intracellular cAMP stimulates the release o f ions and fluid into the lumen of the intestine
from the intoxicated cells with the end result being severe, watery diarrhea (138, 225).
Both enterotoxins have been cloned and sequenced and the genes for the A-and Bsubunits were found adjacent to one another in the same operon. In order to maintain the
5:1 ratio o f B:A-subunits, the ribosome binding site for the B-subunit was found to
promote translation at a higher rate than the ribosome binding site associated with the Asubunit (21).

Escherichia coli also produces two distinct heat-stable enterotoxins (ST1 and
STH) (51, 97). STI is a short, acidic peptide consisting o f 18-19 amino-acids which cause
an increase in intracellular cGMP levels leading to fluid accumulation in the lumen o f the
intestine, in much the same manner as the heat-labile enterotoxin (51, 224, 266). STII
comprises 48 amino-acids and acts by stimulating increased level o f prostaglandin E2 in the
lumen o f the intestine. The effect o f this build up is to induce secretion o f water and
electrolytes into the lumen leading to watery diarrhea (97). Certain strains of C. jejuni
have been shown to increase leukotriene B4, prostaglandin E2, and cAMP levels in rabbit
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ileal loops leading to fluid accumulation (62). These findings suggest the production by C.

jejuni o f an enterotoxin similar to those produced by E. coli and V. cholerae (47, 53).
Another group of bAREs act by transferring the ADP-ribose moiety o f NAD+ to
elongation factor-2 (EF-2) thereby inhibiting eukaryotic protein synthesis (46, 138).
Diphtheria toxin (DT), produced by Corynebacterium diphtheriae, and exotoxin A (ETA)
produced by Pseudomonas aeruginosa, are two examples o f cytotoxins which act in this
fashion (138). Both have been cloned and sequenced but, unlike the enterotoxins
produced by E. coli and V. cholerae, they are single polypeptides with three d o m ains: a
recqptor binding domain, a translocation domain and a catalytic domain (46, 138). Other
bAREs, which include several produced by Clostridium sp., ADP-ribosylate actin filament
and prevent polymerization leading to destruction o f the cell cytoskeleton (94, 138).
Other cytotoxins, which are not part o f the bARE family, have also been
implicated in the inhibition o f protein synthesis (138). The potent toxins produced by

Shigella dysenteriae and E. coli, most commonly referred to as Shiga-toxin and verotoxin
respectively, are toxins which act by inactivating the 60S ribosome, effectively switching
off protein synthesis (181,183, 211). They are multimeric proteins comprised of a
catalytic A-subunit surrounded by 5 B-subunits which, like the B-subunit associated with
the active enterotoxins, are responsible for binding to Gb3 present on host cell surface
(181, 183). Cytotoxin-producing strains o f S. dysenteriae and E. coli have been
implicated in dysentery, diarrhea, hemorrhagic colitus and the more serious condition,
hemolytic-uremic syndrome (HUS) (181). Recently a strain o f Enterobacter cloacae has
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been implicated in a case o f HUS and was shown to produce verotoxin similar to that of

E. co //(192).
Some potent cytotoxins are not only capable o f producing dysentery in the host,
but can induce apoptosis, or programmed cell death in intoxicated cells (45, 105).
Apoptosis is characterized by DNA fragmentation, nuclear condensation and cytoplasmic
blebbing (45, 105). Cytotoxins which interfere with protein synthesis, such as verotoxin
(105) and diphtheria toxin (45) have been found to induce apoptosis. Pore-forming
cytotoxins, such as Staphylococcus aureus a-toxin and E. coli hemolysin, induce
apoptosis possibly by allowing an influx of Na+ (45). The influx o f Na+ has been shown to
induce apoptosis since cells grown in medium without Na+ do not become apoptotic even
though the toxin still induces holes in the cell membrane (45). A summary of toxins
produced by C. jejuni and potentially related toxins together with their mode o f action and
properties are shown in Table 4.1.

4.3 Material and Methods
4.3.1 Effects of C jejuni cytotoxin on cellular cyclic GMP levels.
Organism free filtrate from C. jejuni strain 2483, was obtained as previously
described (section 2.3.1). Two T-75 cm2 flasks (Costar) containing INT-407 (ATCC,
CCL-6) cells were grown to confluency in RPMI-1640 (Sigma) cell culture media
supplemented with 10 % fetal bovine serum (FBS) (Sigma) at 37°C in 5% CO 2. A total
o f 200 fig o f crude, concentrated organism-free filtrate from C. jejuni was added to one of
the flasks and incubated for 24 h at 37°C. Following intoxication, the adherent and non
adherent cells were collected and washed three times with Hank’s balanced salt solution
(HBSS) to remove residual FBS and any cyclic nucleotides contained in the FBS. In order
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Table 4.1. List o f the some o f the more common bacterial toxins along with properties and mode o f action.
Tvpe of Activitv/chanues induced in cells
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Bacterium and toxin

purified

gene
cloned

enterotoxic

cytoskeletal

C. jejuni
enterotoxin

partially

-

+

CLDT

crude

cytotoxin

crude

Yes
-

+
+

Aeromonas hydrophila
aerolysin

purified

Yes

Bordetella pertussis
pertussis toxin

purified

Yes

Clostridium difficile
Toxin A
Toxin B

purified
purified

Yes
Yes

Corynebacterium diphtheriae
diphtheria toxin (DT)

purifed

Yes

purified
purified

Yes
Yes

purified
crude
crude

Yes
Yes
Yes

E. coli
heat-labile enterotoxin a & b
heat-stabile enterotoxin 1 &II
verotoxin I & II
CNF 1 & 2
CLDT

+

+

+
+

cytotoxic

mode o f action

Ref.

elevate cAMP

+
+

-

(53)
(202)
(166)

+

hemolytic

(225)

+

ADP-ribosylates GTP
binding proteins

(138)

secretory

+

ADP-ribosylates actin

(94)
(94)

+

ADP-ribosylates EF-2

(46)

+

elevate cAMP

+

elevate cGMP
ADP-ribosylate EF-2
ND

(225)
(51)
(181)
(225)
(201)

+
+

+
+
+

ND
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Tvoe of Activitv/chances induced in cells
Bacterium and toxin

purified

gene
cloned

enterotoxic

cytoskeletal

crude

No

+

+

crude

No

+

purified

Yes

crude

Yes

Shigella dysenteriae
Shiga toxin I & II

purified

Yes

Staphylococcus aureus
enterotoxins A to E

purified

Yes

Plesiomonas shigelloides
heat-labile enterotoxin
heat-stabile enterotoxin
Pseudomonas aeruginosa
ETA
Salmonella lyphi
LT-like enterotoxin

cytotoxic

+

+

+

+

+
+

mode o f action

Ref.

ND
ND

(225)
(225)

ADP-ribosylate EF-2

(104)

induces secretion

(225)

ADP-ribosylate EF-2

(181)

induces secretion, acts as
a superantigen

(137b)

(225)

alpha toxin

purified

Yes

Vibrio cholerae
CT

purified

yes

+

elevates cAMP

(61)

Yersinia enterocolidca
Heat-stabile enterotoxin I
Heat-stabile enterotoxin II

purifed
crude

yes
no

+
+

elevates cGMP
elevates cGMP

(225)
(225)

ND not determ ined; + = positive reaction; EF-2=elongation factor 2

induces holes in host
cell’s membranes

to calculate the mol cGMP/cell, the cells were stained with trypan blue and counted on a
hemacytometer and the cell numbers were adjusted so that an equal number o f test and
control cells were assayed. Cells were lysed by the addition o f 25% HC1 and the resultant
suspensions were centrifuged at 10,000 xg for 10 mm Supernatant fluids containing the
cyclic nucleotides were removed for assay (51). The supernatants were incubated for 4 h
at room temperature with a known amount o f 1125labeled cGMP (Amersham) and this was
followed by treatment with goat-anti rabbit cGMP antibody (Amersham) (51). The
resulting cGMP-goat-anti rabbit cGMP antibody complexes were precipitated by the
addition o f 80% isopropanol and the amount o f radioactivity in the pellets were
determined on a gamma counter (Beckman Instruments, Inc., Irvine. CA). The amount of
cGMP was expressed as moles o f cGMP/cell from a standard curve and using the formula
below:
total counts/nrin
total number of cells
4.3.2 Evaluation of protein synthesis.
C. jejuni cytotoxic filtrate was prepared as previously described in section 2.3.1.
INT-407 cells were maintained in RPMI-1640 medium supplemented with 10 % FBS and
100 U/ml penicillin and 100 pg/ml streptomycin. A total o f 5x104 INT-407 cells/ml were
seeded into a 96 well plate (Costar) and allowed to grow to about 50-70% confluency.
Prior to the addition o f cytotoxic filtrates, cells were washed three times with HBSS and
the medium was replaced with RPMI-1640 supplemented with 10% FBS without
antibiotics. A total o f 100 pg o f crude, concentrated filtrate from C. jejuni strain 2483
were added to 5 wells each containing INT-407 cells and placed at 37°C in 5% C 0 2 for 23
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h. Five additional wells were tested with 100 p.g o f crude concentrated filtrate from

Corynebacteriitm diphtheriae ATCC strain 13812 as a positive control Pulsing media
(containing

1 /2 0

o f normal leucine levels) alone was used as the negative control to

determine normal levels o f incorporation. After 23 h. the medium was removed from the
cells and replaced with 200 pi pulsing media containing 2|iCi/ml o f L-[3H]-leucine
(Amersham, Arlington Heights, IL) for an additional h at 37°C in 5% C 0 2. Cells were
washed three times with HBSS to remove unincorporated L-[3H]-leucine.
The number of cells per well was determined as previously described (262) by first
fixing the cells in absolute methanol for 10 min, followed by washing with HBSS, then
staining for 30 min with 0.18% (w tv) safranin O at room temperature. Excess stain was
removed by washing three times with HBSS and the cells were lysed by the addition of
1% deoxycholate solution and the OD492 determined using an ELISA plate reader. A 50
pi aliquot o f each o f the test and control wells were added to a vial containing 15 ml o f
Ecohte scintillation fluid (ICN Pharmaceuticals Inc., Case Mesa, CA) and the amount of
radioactivity per vial was determined using a scintillation counter (Beckman Scientific).
The amount o f L-[ 3H]-leucine incorporation was determined from the formula below and
expressed as percent of the control. Greater than 50% decrease in cellular protein
synthesis was considered positive (37).

(ave. cpm o f test wells/ ave. abs test well!
(ave cpm control wells/ave abs o f control wells)

118

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

4.3.3 Effects of C jejuni cytotoxic complex on host cell DNA.
HEp-2 and Vero cells were grown in T-75 cm2 flasks (Costar) in MEM and M 199
media respectively each supplemented with 10% FBS. Twenty-four h. prior to
intoxication, cells were subcultured into a 6-well plate (Costar) containing 3 ml o f fresh
media at a density o f SxlO4 cells. A total o f 5 pg o f cytotoxic protein/ml o f media was
added to the cells for 24 and 48 h. Following incubation, the cells were treated with
trypsin in order to remove them from the 6-well plate. Cellular debris was removed by
layering on a Ficoll-hypaque gradient (Pharmacia Biotech) with a density o f 1.077 and
centrifuging for 30 min at 500 x g. Cells at the interface were removed and washed twice
in PBS. DNA was isolated from viable cells as described previously (232) by
resuspending the pellet in 20 pi lysis buffer, incubating for 1 h at 50°C, and final
incubation for 1 h at 50°C with 10 pi RNaseA (10 mg/ml) (Boehringer Mannheim).
Subsequently, 10 pi o f 10 mM EDTA (pH 8.0) and 8 pi o f 6X sample buffer were added
to the DNA mixture and the mixture heated to 70°C for 10 min prior to the loading of
samples into the dry wells o f a 2% agarose gel along with Hind lH digested lambda DNA.
Gels were run for 5 min with buffer only in contact with the ends o f the gel before
overlaying the entire gel with buffer and running to completion. Gels were stained with
0.5 pg/ml ethidhun bromide (Sigma) and viewed on a transilluminator.

4.4 Results
4.4.1 Effects of cytotoxic filtrate on cellular processes.
Following intoxication o f INT-407 cells with C. jejuni cytotoxic filtrate, cellular
cGMP levels and protein synthesis capabilities were measured by radio-immunoassay and
incorporation o f L -[^ -le u c in e respectively. The unintoxicated control ENT-407 cells in
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the cGMP level determination assay were found to contain 2.63 X 1O'20 mol cGMP/cell
while intoxicated cells contained 2.7 XIO'20 mol cGMP/cell (Fig 4.1).
The effects o f filtrate on host cell protein synthesis was based on the average o f
five wells for each o f the control and test wells and was expressed as a percent of normal
protein synthesis present in the control cells (Fig 4.2). Cells intoxicated with C. jejuni
cytotoxic filtrate gave 16% o f the protein synthesis activity as compared to the unaffected
control. The positive control cells intoxicated with diphtheria toxin, possessed 13% o f
normal protein synthesis as compared to the control Since readings greater than 50%
decrease in incorporation are considered significant (37) and since the control diphtheria
induced a reduction o f 87% in protein activity, the reduction o f 84% resulting from C

jejuni indicated that the toxin significantly affected host cell protein synthesis.
4.4.2 Effects of cytotoxic porin-LPS complex on cellular DNA.
Qualitative analysis o f the effects elicited by the purified cytotoxic complex
produced by C. jejuni on cellular DNA are shown in Fig 4.3. The results showed that the
complex induced DNA fragmentation in HEp-2 cells as early as 24 h following
intoxication as compared to control DNA. Vero cell DNA was unaffected by the
cytotoxic complex at both 24 and 48 h. The cytological changes elicited by the complex in
HEp-2 cells were typical o f the effects induced by the isolated porin-LPS complex (section
2.4.1). However, intoxicated Vero cells lacked vacuole formation, cytoplasmic blebbing,
nuclear condensation and rounding which were characteristic o f the progression of the
cytotoxic activity observed in HEp-2 cells.
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Figure 4.1
Effects on the cellular levels o f cGMP of 100 fig crude, concentrated cytotoxic
filtrate from C. jejuni, strain 2483 on INT-407 cells after 24 h intoxication. The amount
of cGMP was determined by RIA and calculated from a standard curve using known
concentrations o f cGMP and expressed as mol cGMP/ celL
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Figure 4.2
Effects o f the cytotoxic filtrate from C. jejuni, strain 2483, on INT-407 cell protein
synthesis. The amount o f L-[3H]-leucine incorporated in nascent proteins was an average
of 5 test wells and expressed as a percent of the control Less than 50% decrease in
protein synthesis as compared to the control was considered significant. Control INT-407
cells: unintoxicated; C. jejuni cytotoxic filtrate: INT-407 cells were intoxicated with 100
(ig crude filtrate from C. jejuni, strain 2483; C. diphtheriae cytotoxic filtrate: INT-407
cells intoxicated with 100 pg crude filtrate from Coryiiebacterium diphtheriae ATCC
strain 13812.
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Figure 4.3.
Effects on HEp-2 and Vero cell chromosomal DNA of C. jejuni 2483 isolated
porin-LPS complex. Lane 1 and 8: HindUl digested lambda DNA; lane 2 Control
unintoxicated HEp-2 cell DNA; lane 3: HEp-2 cells DNA following intoxication with 5
pg/ml o f C. jejuni cytotoxic complex for 24 h; lane 4: HEp-2 cells DNA following
intoxication with 5 pg/ml o f C. jejuni cytotoxic complex for 48 h; lane 5: Control
unintoxicated Vero cell DNA; lane 6: Vero cell DNA following intoxication with 5 |ig/ml
of C. jejuni cytotoxic complex 24 h; lane 7: Vero cell DNA following intoxication with 5
pg/ml o f C. jejuni cytotoxic complex for 48 h.
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4.5 Discussion.
Little is known regarding the mode o f action o f exotoxins produced by C. jejuni.
Everest et al. (62) reported an elevation o f leukotriene B4, prostaglandin and cAMP in
rabbit ileal loops following infection with some strains o f C. jejuni which was similar to
that produced by V. cholerae and E. coli heat-labile enterotoxin. C. jejuni has also been
shown to produce heat-stable or labile alpha- and beta-hemolytic toxin (62, 99).
Preliminary experiments using purified C. jejuni cytotoxin failed to lyse chicken, horse or
rabbit erythrocytes in vitro under physiologic conditions (personnel communication with
C. Clark). Misawa et aL (162) documented visible hemolysin production by certain strains
o f C. jejuni when grown on 5% sheep blood agar. However, the strain o f C. jejuni used
in the purification o f the cytotoxic protein did not produce a visible hemolysin when
grown on tryptic-soy agar plates containing 5% sheep blood for 48 h.
Other exotoxins produced by Campylobacter spp. and closely related organisms
have been reported (79, 225, 257). The most characterized to date is the vacuolating
cytotoxin produced by Helicobacter pylori (48) but its molecular weight, purification
characteristics and amino acid composition appears quite distinct from the purified C.

jejuni cytotoxic protein described in these studies. However, as stated earlier, at the onset
o f cytotoxicity in HEp-2 cells, vacuoles form in the cytoplasm o f intoxicated host cells and
these appear similar to those induced by the vacuolating cytotoxin o f H. pylori (48, 247).
Vacuole formation by H pylori cytotoxin can be reversed in vitro by the addition of Vtype ATPase inhibitors and potentiated by inhibitors o f Na+-K+ ATPase (247). This
suggests that the mechanism o f action o f the H. pylori cytotoxin is due to atypical cation
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transport within host cells (247). The effects o f ATPase inhibitors on the formation of
vacuoles induced by C. jejuni cytotoxic complex still remains to be elucidated.
Another toxin produced by a related species Wolinella ( Campylobacter) rectus has
been partially purified and characterized (79). The molecular weight is in excess o f 100
kDa and the N-terminal structure suggests that it is similar to the leukotoxin produced by

Actinobacillus actinomycetemcomitans. The N-terminal sequence o f the cytotoxic protein
purified from C. jejuni does not share homology with known leukotoxins (section 2.4.2)
but like the leukotoxin produced by A. actinomycetemcomitans, the cytotoxic material
from C. jejuni is closely associated with LPS. A leukotoxin has been described as being
produced by C. jejuni, but it has yet to be purified and characterized (129).
Elevation o f cyclic nucleotides (cGMP and cAMP) are well characterized effects
o f enterotoxins (138). Unlike the heat-stable enterotoxin produced by E. coli (51), C.

jejuni cytotoxic filtrate failed to increase cellular levels of cGMP. Enterotoxins (CT and
LT) also caused CHO cells to become elongated when intoxicated, but eventually the cells
revert back to their normal shape since cytotonic enterotoxins do not induce permanent
morphological changes in these cells. Cytotoxins are readily distinguishable from
enterotoxins in cell culture assay as they cause cells to round up and become highly
refractde. Unlike the reversible action o f enterotoxins, cytotoxin treated cells do not
recover following intoxication (225). Cells exposed to the C. jejuni cytotoxic protein,
showed no elongation but rather the permanent rounding typical o f a cytotoxic response.
Previous studies by Johnson et a/.(108) showed that toxic filtrates from C. jejuni caused a
1-1.3-fold increase in cAMP depending on the strain tested while cholera and E. coli LT
caused 85-180-fold increases in cAMP (108). As a consequence o f these findings, the
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effects on host cell processes dicited by known cytotoxins were investigated in greater
detaiL
The experiment using L-f3!!]-leucine was designed to determine the effects o f C.

jejuni cytotoxin on cellular protein synthesis and the results showed a significant decrease
in incorporation o f a radio-labeled amino acid following intoxication. Further studies are
required to determine if the cytotoxin induces holes in the cell membrane similar to

Staphylococcus aureus a-toxin permitting the release o f Mg2+/Ca2+which are vital for
normal cellular processes. Other experiments, such as in vitro transcription/translation
techniques using rabbit reticulocytes, can be used to determine if the cytotoxin directly
effects protein synthesis. However, this experiment cannot distinguish between
inactivation o f the ribosomes and ADP-ribosylation o f elongation factor-2 (46, 211).
Studies using C 14 labeled NAD* and elongation factor-2 can be used to distinguish
between the tw o steps (46).
Apoptosis, or programmed cell death, is involved in maintaining the proper number
o f cells during development and for homeostasis (45). Several mechanisms, such as the
generation o f nitric oxide, protease production and the release of Ca2+ from the
mitochondria are involved in the apoptotic process (45, 212). The cytotoxic complex
from C. jejuni elicits cytological changes in host cells in a similar manner to verotoxin type
1, which also induces apoptosis but in Vero cells (105). Inhibition of protein synthesis,
either by inactivating the 60 S ribosome as effected by verotoxin and shiga toxin (181,
211) or ADP-ribosylating elongation factor-2 as induced by diphtheria toxin (46) have
been shown to induce apoptosis as well (105). Inhibition o f DNA synthesis could also be
caused by the release ofM g2+/Ca2+ from intoxicated cells. The inhibition o f de novo DNA
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synthesis by the addition o f the transcription inhibitor actinomycin D has also been shown
to induce apoptosis (198). Recently, Shiga toxin has been shown to induce nitric oxide
production in macrophages but whether or not this leads to apoptosis was not determined
(274).
Since the C. jejuni cytotoxic complex was unable to induce DNA fragmentation in
Vero cells and had very little cytotoxic effects on these cells, the results suggest that the
receptors specific for binding the cytotoxin are more prevalent on the surface o f HEp-2
than Vero cells. The nature o f the cytotoxin is not known but preliminary results, in
conjunction with Dr. Glen Armstrong at the University o f Edmonton, Alberta, Canada,
suggest a ganglioside similar to GMi (personal communication with G. Armstrong).
However, the receptor was found to be quite distinct from the verotoxin receptor Gb3
(globotriaosylceramide) (7, 181).
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SECTION V
Concluding remarks
5.1 General Discussion
C. jejuni has been shown to produce several unique exotoxins (225, 257). The
toxins have been found to be either heat-labile (85, 109, 150) or heat-stable (143) and are
either sensitive or resistant to degradation by trypsin (85, 150). C. jejuni, is a gram
negative organism and hence expresses LPS, a potent endotoxin; however, there have
been no reports regarding the possible role of the LPS in toxicity. In the present study, a
cytotoxic complex has been detected and found to be associated with an isolated bacterial
fraction rich in LPS.
The sequence data obtained from the protein component o f the cytotoxic complex
showed that it was similar to the porin protein isolated from the outer membrane of C.

jejuni strain 85H (26) as well as the membrane proteins from W recta (117). However,
the only reported information regarding the C. jejuni porin concerns its pore forming
capabilities (103) and the fret it has been classified as a member o f the microbial trimeric
porin family (26). SDS-PAGE using isolated denatured porin protein preparations
showed it to posses a molecular weight o f approximately 45 kDa (26, 103) and to have a
p i o f 4.35 (26). The data presented here confirmed these finding for molecular weight and
pL The production o f an apoptotic, porin-LPS complex produced by C. jejuni as well as
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certain related organisms may explain why the cytotoxin, known to be produced by these
organisms, has proved so elusive. Indeed, several reports have documented the presence
o f a cytotoxin but until now there has been no information on the N-terminal sequence.
Published accounts offer speculative determinations o f cytotoxic proteins o f a variety of
sizes (85, 166) and this has made it difficult to formulate accurate comparisons between
cytotoxins. However, Guerrant et al (85) reported the production and characterization of
a heat-labile and mildly trypsin-sensitive protein with a molecular mass greater than 14
kDa as determined by gel filtration column chromatography. They also indicated that the
cytotoxic activity could not be neutralized with anti-Shiga-like toxin (verotoxin) (85).
This was contrary to a report by Moore et al. (167) in which the production of a Shigalike cytotoxin from C. jejuni was documented. In the present study, results regarding the
isolated porin-LPS showed that toxicity was heat-labile, was resistant to trypsin
degradation and produced characteristic morphological changes in cells in culture similar
in appearance to those induced by verotoxin; however, these could not be neutralized with
antisera against either E. coli VT1 or VT2. Also, PCR experiments using primers specific
for E. coli VT1 and VT2 M e d to produce amplicons suggestive o f similar intact
verotoxin genes.
The nature and the timing o f morphologic changes induced in various cell cultures
by the porin-LPS complex appeared to be dose dependent. At the higher concentration of
10 |ig o f protein/cell culture well, vacuoles were formed rapidly but these dissipated
within the first 12 h after intoxication. By 48 h after intoxication, 80-100% of the cells
appeared rounded and refractile. At the lower concentration of 1 pg o f protein/cell
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culture well, the vacuoles persisted for up to 48 h post-intoxication and the rounding and
refractile nature o f the cytotoxic changes become more apparent at 72 h. On careful
examination, the vacuoles have an appearance similar to those produced by H. pylori in
affected cells(50). PCR experiments using primers specific for the vacA and cagA genes
failed to produced amplicons and suggested that neither o f these genes were present in C.

jejuni. The purified vacuolating cytotoxin from H. pylori has a molecular weight of 87
kDa when examined under denaturing conditions (49); almost twice the molecular weight
o f the porin found in C. jejuni.
The carbohydrate component o f the LPS was characterized using a series o f lectins
conjugated to alkaline phosphatase. The positive results with the lectins Galanthus nivalis
agglutinin (GfNA), Maackia amurensis agglutinin (MAA) and Datura stramonium (DSA)
indicated that the carbohydrate possessed terminally linked mannose and sialic acid
terminally linked a(2-3) to galactose as well as galactose-P( l-4)-N-acetylglucosamine
complexed together with hybrid N-glycan structures (see Table 2.1). The Penner
serotyping scheme for Campylobacter is based on the heat-stable 0 antigen o f the
organism and strain 2483 was found to be 0:11. It is unfortunate that currently there is no
information regarding the carbohydrate composition o f the LPS from this serotype;
however, the positive lectin results suggested that LPS from 0 : 11 was similar to that for
serotypes 0 :2 and 0 :4 (10,11). Infections with these serotypes which have been
implicated in Guillain-Barre syndrome (GBS). GBS is a severe degenerative neurological
autoimmune disease which is thought to occur due to the molecular mimicry that exist
between the LPS from certain strains o f C. jejuni and the gangliosides present on human
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nerve cells (8,27"’). It is speculated that infections with certain serotypes o f C. jejuni
possessing ganglioside-like molecules enhance an immune response directed against
ganglioside GMi, GDu, GDu> and GTib present on the human nerve cells leading to
demyelation. GBS can be a long term debilitating disease and in some instances may be
life threatening which has led to an increase in the mortality and morbidity rates associated
with cases o f campylobacteriosis.
Toxicity of the porin-LPS complex was found to be associated with the protein
component. This critical finding was confirmed using several methods: 1) the most
convincing was that the toxicity o f the complex was heat-labile at 70°C for 30 min; 2)
attempted degradation o f the cytotoxic complex using the enzymes neuriminidase and
glycosidase F each o f which target the structures identified with the lectins MAA and DSA
respectively were to no effect; 3) oxidation of the carbohydrate component o f the porinLPS complex with 10 mM sodium meta-periodate also had no effect on toxicity when
tested in HEp-2 or HeLa cells. Since toxicity was maintained following oxidation and
glycosidase treatments, adherence o f the complex to host cells is most likely mediated via
the porin component. These findings are contrary to a previous report (154) in which it
was stated that LPS was involved in adherence o f the organism to HeLa cells and that this
property was lost following oxidation with sodium meta-periodate. Yet another report
(66) indicated that the porin was not involved in adherence to HeLa cells.
As shown in the present study, using Giemsa staining o f intoxicated cells, the
porin-LPS complex was able to induce DNA fragmentation in HEp-2 cells but not in Vero
cells. This fragmentation is characteristic o f cells that are in the process of becoming
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apoptotic. Furthermore, cytoplasmic blebbing and nuclear condensation are also common
characteristics o f cells undergoing apoptosis (45,212). HEp-2 cells intoxicated with the
porin-LPS complex from C. jejuni strain 2483 showed cytoplasmic blebbing and nuclear
condensation effects typical o f apoptosis. Similar findings have been reported for VT1, an
apoptotic cytotoxin fro m f. coli (105). The effects o f crude concentrated bacterial-cellfree filtrate from C. jejuni 2483 containing the porin-LPS cytotoxic complex was also
found to significantly effect the ability o f human INT-407 cells to incorporate ^-leucine
in nascent peptides. However, the cytotoxic filtrate had no effect on cGMP levels, a well
reported mode o f action for the E. coli heat-stable enterotoxin (51, 224).
Inhibition o f protein synthesis by bacterial toxins has been shown to lead to
apoptosis in affected cells (45). E. coli verotoxin and C. diphtheriae toxin are two
examples o f cytotoxins that induce apoptosis by the inhibition o f protein synthesis (45).
Since, the porin-LPS complex from C. jejuni was found to be distinct from E. coli VT1, it
may act in a manner similar to S. aureus a-toxin which induces apoptosis by creating holes
in affected host cell membranes leading to the release of Mg2+, Ca2+ and other components
vital to cell function. The complex described in this study may function by inserting itself
into host cell membranes creating a functional porin similar to that present in the outer
membrane o f C. jejuni (26, 103). The porin from C. jejuni UA580 was found to form a
small cation selective channel (103) which could facilitate the release ofM g2+ and Ca2+
from intoxicated cells.
Purified porins have been shown to be cytotoxic to host cell and serve as adjuvants
for enhancing immune responses (23, 54, 76, 77). Porins from S. typhimurium have been
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shown to act specifically on the cytoskeleton ofHEp-2 cells (54) while porins from

Neisseria inhibit actin polymerization as well as degranulation, opsonin receptor
expression and phagocytosis in neutrophils (23). Either method may serve the organism
and assist it to escape the protective capabilities o f the host’s defence system. In addition,

S. typhimurium porins independent o f LPS are capable o f inducing an inflammatory
response in rat paws (77). In these animals, histamine release from rat peritoneal cells was
dose dependent as was the development o f edema which reached a peak response 2 to 3 h
after porin injection. However, edema was markedly reduced if the rats were first treated
with anti-histamines but not if the rats were decomplemented (77). This shows that porins
are capable o f inducing edema leading to an inflammatory response independent of the
complement system (77). Based on the cytotoxicity and inflammatory responses elicited
by porins, it is clear that they should be considered bacterial virulence factor per se (54,
513, 77).
The porin-LPS complex may not be produced by the organism in response to
adverse conditions encountered by the organism The cytotoxicity elicited by the porinLPS is most likely accidental and may be a by-product o f cell growth and death (513).
The porin from C. jejuni may serve tw o functions: 1) to allow for the exchange of
material between the environment and the organism (103, 176); and 2) to serve as a
method which permits the organism to survive better in the environment within the host as
it becomes less favorable by releasing nutrients from host cells in the gut (156) or when it
is acted upon by the defense system The porin-LPS structure may oligomerize in the
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membranes and form small cation-selective channels in much the same way as the
hemolysin HlyA produced by V cholerae forms anion selective channels (156).
The sequence data obtained from the N-terminal o f the isolated protein was used
to construct oligonucleotides which were subsequently used with a combination o f
vectorette PCR (213), inverse PCR and cloning to sequence the porin gene. The detected
and sequenced gene was designated porA. The porA gene consisted o f a 1275 bp ORF
which encoded a protein consisting o f 424 amino acid. This had a molecular weight of
45.6 and a p i o f 4.44. The %G+C content was found to be 36.7 mol % which was slightly
higher than previously described by Taylor et al (246). This increase in %G+C may
explain why certain codons were used more frequently than those previously described in
a compilation table available through Genbank. The mature protein contained a 22 amino
add protein which was cleaved prior to insertion yielding a final protein component with a
molecular mass o f 43.5 kDa and a pi o f 4.35 and this was similar to that previously
described (103, 26). The gene contained a typical Shine-Dalgamo sequence and a
previously published -35 region (199) and a putative -10 site. There was also a strong
rho-independent transcription termination sequence (4) which consists of a 9 bp dyad
separated by a 5 bp loop and a poly T region immediately distal to the stem o f the loop.
Comparative analysis o f the ORF using BLAST showed it had the largest
homology with H. influenzae P2 DNA (91) over short stretches and a 50% sequence
similarity but only a 23% sequence identity with the translated P2 protein. PorA also had
significant sequence similarity with Enterobacter cloacae PhoE, K. pneumoniae PhoE, S.

typhi OmpC and E. coli PhoE even though sequence identity was low. Sequence
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similarity can be used to help define the functionality o f the PorA protein compared to
other well known porins and may also be used to compare the secondary structures as well
(176).
The relative amounts o f basic, polar and acidic residues are similar to that of H.

influenzae P2 and the enterobacterial consensus sequence but the present study showed
that there are a greater frequency o f hydrophobic residues in the porin from C. jejuni. The
molecular weight o f H. Influenzae P2 is 39.7 kDa while the enterobacterial consensus
sequence is approximately 35 kDa. Since PorA is larger, it is not surprising that it
contains more hydrophobic residues which may result from greater concentrations of
intra-membrane (3-pleated sheets. This is evident when the hydrophobic and beta sheet
charts from these three porin, calculated by the method of Novotny (179), were
compared. C. jejuni PorA was estimated to contain 12 membrane spanning domains as
compared to 8 for the enterobacterial consensus sequence and Rhodobacter capsulatus
porin (176).

5.2 Conclusions
The identification and characterization of the cytotoxic effects elicited by the major
outer membrane porin protein from C. jejuni had not been documented prior to these
studies. The close association maintained between the porin protein and the LPS made the
complex difficult to isolate and this may offer an explanation as to why the cytotoxin
known to be produced by C. jejuni has been so difficult to describe. The DNA sequencing
of the porA gene allows for more comprehensive studies in the future, in particular with
respect to the role PorA protein plays in campylobacteriosis. Cloning and expression of
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PorA may also lead to a possible recombinant vaccine. A recombinant vaccine could
lessen the severe and sometimes fatal sequelae associated with C. jejuni infections
permitting a reduction in overall health costs.
In conclusion, C. jejun i is an enteric pathogen that can induce a severe form of
gastroenteritis resulting in dysentery or blood and mucus in the stooL From these studies
it is postulated that the disease induced in humans by C. jejuni is due to the cytotoxic
effects on host cells in the gut arising from the expression of the porA gene and that the
PorA porin-protein product influences host cell protein synthesis. This damage
contributes to the symptoms observed in campylobacteriosis.
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APPENDICES
Appendix 1: Biological studies
A. Bacterial cultivation and storage.
1.1

C. jejuni strain 2483 was passed once prior to the beginning o f the study and was
maintained at -80C on trypic soy broth supplemented with 5% sheep blood.
Virulence was assessed after passage by the fertile hens egg model (150).

1.2

5% Blood agar plates
Blood agar plates were prepared adding 25 ml sheep blood to 475 ml sterile
tryptic soy agar which had been autoclaved and allowed to cool to about 50 °C
prior to the addition o f the blood. Plates were poured and allowed to cool
overnight at room temperature.

1.3

Glycerol Peptone water
The strains o f bacteria obtained from the Laboratory Centre for Disease Control in
Ottawa, Canada were maintained at -80 °C on sterile glycerol peptone prepared
by:
Component

Amount

glycerol
neopeptone
NaCl
ddH20

250 ml
10g
5g
750 ml

The solution was adjusted to a pH o f 7.0 then autoclaved in 15 ml aliquots and
stored at 4 0C until needed.
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B. Cell culture
1.4

Hanks Balanced Salt Solution (HBSS)
Sterile batches o f 500 ml lOx concentrated solution was purchased from Sigma
Chemical Company. A total of 50 ml o f sterile HBSS was added to 450 ml sterile
ddH20 and the pH was adjusted with sterile Na 2HCC>3. The solution was stored at
4 °C until needed.

1.5

Sodium bicarbonate
A 7.5% solution o f Na 2HC (>3 was prepared by adding 7.5 grams of Na2H C 03.
to 100 ml ddH20 then filter sterilized using a 0.22 |xm syringe filter. The stock
solution was stored at 4°C until needed.

1.6

Sodium hydroxide
A IN NaOH solution was made by adding 4 g NaOH pellets to 100 ml ddH20 and
sterilized by autoclaving.

1.7

Fetal Bovine Serum
Sterile fetal bovine serum was purchased from Sigma Chemical Company and
aliquoted into 25 ml batches and stored at -20 °C until needed.

1.8

lOx Phosphate buffered Saline (PBS)
The buffer was prepare by the formulation:
Component

Amount (g/Ll

NaCl
KC1
KH2PO4
Na2HP04

80.0
2.0
2.0
1.5
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H ie buffer was pH to 7.0 with 10 N NaOH and diluted 10-fold prior to use with
ddH20 .
1.9

Minimal essential media (MEM)
HEp-2, HeLa and CHO cells were maintained in MEM supplemented with 10 %
FBS. Sterile 10 x MEM was purchased from Sigma Chemical company and 500
ml batches o f media were prepared by.
Component

Amount

Sterile ddH20
MEM
FBS
L-glutamine
7.5 sodium bicarbonate

377 ml
50 ml
50 ml
18 ml
5 ml

The media was adjusted to pH 7.2 with sterile 10 N NaOH was sterility tested by
plating an aliquot to both a nutrient and blood agar plate.
1.10

RPMI-1640
INT-407 cells were maintained in RPMI-1640 media supplemented with 10 %
FBS. Sterile 10 x RPMI-1640 was purchased from Sigma Chemical company and
500 ml batches o f media were prepared b y
Component

Amount

Sterile ddH20
RPMI-160
FBS
L-glutamine
7.5 sodium bicarbonate

377 ml
50 ml
50 ml
18 ml
5 ml

The media was adjusted to pH 7.2 with sterile 10 N NaOH was sterility tested by
plating an aliquot to both a nutrient and blood agar plate.
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1.11

Tiypsm-EDTA (0.05% to 0.02%)
A 500 ml working solution was prepared by adding the following ingredients to a
500 ml b eaker
Component

Amount

EDTA
trypsin
Ca+ and Mg* free saline
phenol red

100 mg
250 mg
500 ml
50 mg

The solution was filter sterilized with a 0.22 pm filter and in 25 ml aliquots at
-20°C until needed.

Appendix 2: M olecular Biology studies
A. Protein analysis

2.1

Lower gel buffer
Lower gel was prepared as follows:
Component

Amount

Tris
SDS

18.4 g
4.0 g

ddH20 was added to final volume o f 1 L and the pH adjusted to 8.9. The solution
was stored at 4°C until needed.
2.2

Upper Gel buffer
Upper Gel buffer was prepared as follows:
Component

Amount

Tris
SDS

60.5 g
4.0 g
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ddH20 w as added to final volume o f 1 L and the pH adjusted to 6.8. The solution
was stored at 4°C until needed.
2.3

2 x SDS sample buffer
2 x SDS sample buffer was prepared as follows:
Component

Amount

glycerol
SDS
Tris
mercapto-ethanol
1% Bromophenol blue

lOOg
23 g
7.56 g
50 ml
1 ml

ddH20 w as added to final volume o f 1 L and the pH adjusted to 6.8. The solution
was stored at room temperature until needed.
2.4

30% SDS slab aciylamide
An acrylamide solution was prepared as follows:
Component

Amount

acrylamide
bis-acrylamide

292 g
8g

ddH20 w as added to final volume o f 1 L and the solution was stored at 4 ° C until
needed.
2.5

10 x Running Buffer
10 x SDS-PAGE running buffer was prepared as follows:
Component

Amount

Tris
Glycine
SDS

30 g
144g
lOg
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ddH20 was added to final volume o f 1 L. The buffer was diluted to IX with
ddH20 before use.
2.6

Western transfer buffer.
10 x SDS-PAGE running buffer was used for Western transfer with the addition o f
20 % methanol to the 1 x working solution.

2.7

10% Ammonium Sulfate
Ammonium sulfate was prepared as follows:

Component

Amount

ammonium sulfate

1g
9.4 ml

ddH20

lml aliquots were stored at -20 °C until needed.
2.8

Coomassie Brilliant Blue R-250 stain (0.125%)
Coomassie blue was prepared as follows:
Component

Amount

Coomassie Brilliant Blue R-250
methanol
glacial acetic acid
ddH20

1.25 g
50%
7%
to one liter

The stain was filtered using Whatmann filter paper and stored at room
temperature.
2.9

Destain for Coomassie Brilliant Blue R-250 stain
Destain was prepare a follows:
Component

Amount

methanol

50%

glacial acetic acid
ddH20

7%
to one liter
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The solution was stored at rom temperature.

B. Agarose gel electrophoresis
2.10

6X sample buffer
Agarose sample buffer was prepared as follows:
Component

Amount

bromphenol blue
xylene cyanol
ficoll 400

0.25%
0.25%
15%

dcLH^O was added to a final volume o f 50 ml and the solution was stored at room
temperature.
2.11

10X Tris-acetate, EDTA (TAE)
TAE buffer was prepared as follows:
Component

Amount

Tris-Acetate
EDTA
glacial acetic acid

0.4 M
0.1 M
0.2 M

d d l^O was added to a final volume o f 1 liter and the pH was adjusted to 8.4 at
25 °C.

C. Southern Hybridization
2.12

20 xSSC
20 x SSC was prepared as follows:
Component

Amount

NaCl
sodium citrate

3M
0.3 M
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ddH20 was added to 1 L and the pH adjusted to 7.0. The stock was diluted with
ddH20 to desired concentration prior to use.

2.13

Denaturing solution
Denaturing solution was prepared as follows:
Component

Amount

NaOH
NaCl

0.5 M
1.5 M

ddH20 was added to 1 L.
2.14

Neutralizing solution
Neutralizing solution was prepared as follows:
Component

Amount

Tris-HCl
NaCl

0.5 M
1.5 M

ddH20 was added and the pH adjusted to 7.5.
2.14

Hybridization solution
Hybridization solution was purchased from Gibco-BRL and was prepared by the
manufacturer as follows:
Component

Amount

SSC
EDTA
Denhardt’s solution
SDS
sheared denature,
salmon sperm DNA

6x
0.01 M, pH 8.0
5x
0.5 % (w/v)
100 pg/ml
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The hybridization solution was aliquoted into 10 ml tubes and stored at -20 ° C
until needed.
2.15

10 X low salt Tris-buffered saline (TBS)
10X TBS low Salt was prepared as follows:
Component

Amount

TrizmaBase
NaCl

121.1 g
87.66g

ddH20 was added to a final volume o f 1 L and the pH adjusted to 7.0.
2.16

Washing buffer
Washing buffer was prepared as follows:
Component

Amount

Tris-HCL, p H 9.5
NaCl
MgCl2

0.1 M
0.1 M
50 mM

This solution was used to equilibrate the membranes to the proper pH and MgCl2
concentration prior development with either CPD-star or BCIP and NBT.

D. Polymerase chain reaction
2.17

PCR reaction buffer
10 x PCR buffer was prepared as follows:
Component

Am ount

KC1
Tris-HCl
Triton X -100
MgCfe

500 mM
100 mM
1%
30 mM

ddH20 was added to a final volume of 100 ml and the pH was adjusted to 8.3.
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2.18

10 x Dinucleotide diphosphates (dNTP’s)
dNTP’s were purchased from Sigma Chemical Company and reconstituted to a
concentration o f 200 pM o f each dATP, dGTP, dCTP, d i 1’P. 1 ml aliquots were
stored at -20 °C until needed.

2.19

PCR reaction mixture
PCR reaction mixture was prepared as follows:
Component

Amount

primers
dNTP’s mixture
10 x PCR reaction buffer
Taq DNA Polymerase (5 units/pl)

1 pM each
200 pi
100 pi
22 pi

Sterile d d U O was added to a final volume o f 1000 pi and was stored at -20 °C
until needed. Taq DNA polymerase was purchased from Promega in 20 pi
aliquots and was stored at -20 °C until needed.

C. M ode of action studies
3.1.

Pulsing media
Pulsing media was used in the protein inhibition studies and prepared as indicated
below:
Component

Amount

10 x HBSS
10 ml
10X RPMI-1640
0.5 ml
(1/20 o f normal leucine concentration)
2pCi/ml L -f^-leu cin e
dcfflbO
to 100 ml
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The radioactive leucine was added prior to use and only the amount required to
perform the experiments was prepared
3.2

Lysis buffer
The cells evaluated for DNA fragmentation were lysed by the addition of a buffer
containing:
Component

Amount

Tris-HCl, pH 8.0
laurylsarcsinate
proteinase K

50 mM
0.5%
1.25 mg/ml

A 50 ml stock solution was prepared and stored at room temperature until
required.
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